WO2012174096A2 - Compositions de soins personnels comprenant un agent gélifiant di-amido et procédés d'utilisation - Google Patents

Compositions de soins personnels comprenant un agent gélifiant di-amido et procédés d'utilisation Download PDF

Info

Publication number
WO2012174096A2
WO2012174096A2 PCT/US2012/042228 US2012042228W WO2012174096A2 WO 2012174096 A2 WO2012174096 A2 WO 2012174096A2 US 2012042228 W US2012042228 W US 2012042228W WO 2012174096 A2 WO2012174096 A2 WO 2012174096A2
Authority
WO
WIPO (PCT)
Prior art keywords
bis
azanediyl
diylbis
diyl
dibenzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2012/042228
Other languages
English (en)
Other versions
WO2012174096A3 (fr
Inventor
Susana Fernandez Prieto
Johan Smets
Beatriu Escuder Gil
Juan Felipe Miravet Celades
Vicent Josep NEBOT CARDA
Paul Robert Tanner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to JP2014515956A priority Critical patent/JP2014524901A/ja
Priority to EP12729303.3A priority patent/EP2717966A2/fr
Priority to CN201280028925.6A priority patent/CN103930167A/zh
Publication of WO2012174096A2 publication Critical patent/WO2012174096A2/fr
Anticipated expiration legal-status Critical
Publication of WO2012174096A3 publication Critical patent/WO2012174096A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/48—Thickener, Thickening system

Definitions

  • compositions comprising a di-amido gellarit that is compatible with a broad range of personal care ingredients.
  • compositions include anti-aging lotions, after-shave balms, hair styling products, mascaras, and the like.
  • Structurants are typically selected based upon the particular phase being structured. Structurant selection may be limited if the composition includes reactive materials such as anionic species that can complex with cationic structurants. Structurant selection may be further limited given the pH of the personal care composition. Low or high pH can limit the efficacy of many structurants.
  • compositions comprising a di-amido gellant, wherein the di-amido gellant has a formula:
  • Ri and R 2 are aminofunctional end-groups which may be the same or different, and L is a linking moiety of rholecular weight from 14 to 500 g/mol; and wherein the personal care composition is a leave-on composition.
  • a personal care composition in the form of an emulsion comprising an aqueous phase, an oil phase, and a di-amido gellant as previously described.
  • a personal care composition comprising a di-amido gellant, as previously described and an active or agent selected from a group consisting of sugar amines, vitamins, oil control agents, photosterols, hexamidine compounds, tightening agents, anti-wrinkle actives, anti-atrophy actives, flavonoids, N-acyl amino acid compounds, retinoids, peptides, particulate materials, UV actives, photostabilizers, anti-cellulite agents, desquamation actives, anti-acne actives, antioxidants, radical scavengers, conditioning agents, anti-inflammatory agents, tanning actives, skin lightening agents, botanical extracts, antimicrobial actives, antifungal actives, antibacterial actives, antiperspirant actives, sensates, preservatives, anti-dandruff actives, substantivity
  • compositions of the present invention can comprise, consist essentially of, or consist of, the essential components as well as optional ingredients described herein.
  • “consisting essentially of” means that the composition or component may include additional ingredients, but only if the additional ingredients do not materially alter the basic and novel characteristics of the claimed compositions or methods.
  • compositions suitable for topical application on mammalian keratinous tissue means compositions suitable for topical application on mammalian keratinous tissue.
  • applying means to apply or spread the compositions of the present invention onto keratinous tissue such as the epidermis.
  • keratinous tissue refers to keratin-containing layers disposed as the outermost protective covering of mammals (e.g. , humans, dogs, cats, etc.) which includes, but is not limited to, skin, lips, hair, toenails, fingernails, cuticles, hooves, etc.
  • compositions or components described are suitable for use in contact with human skin tissue without undue toxicity, incompatibility, instability, allergic response, and the like.
  • the term "safe and effective amount” means an amount of a compound or composition sufficient to significantly induce a positive benefit.
  • the term “leave-on,” in reference to compositions, means compositions intended to be applied to and allowed to remain on the keratinous tissue. These leave-on compositions are to be distinguished from compositions which are applied to the skin and subsequently (in a few minutes or less) removed either by washing, rinsing, wiping, or the like. Leave-on compositions exclude rinse-off applications such as shampoos, facial cleansers, hand cleansers, body wash, or body cleansers. The leave-on compositions may be substantially free of cleansing or detersive surfactants. For example, "leave-on compositions" may be left on the keratinous tissue for at least 15 minutes.
  • leave-on compositions may comprise less than 1 % detersive surfactants, less than 0.5% detersive surfactants, or 0% detersive surfactants.
  • the compositions may, however, contain emulsifying or other processing surfactants that are not intended to provide any significant cleansing benefits when applied topically to the skin.
  • derivatives means an ester, ether, amide, hydroxy, and/or salt structural analogue of the relevant compound.
  • to structure means to increase viscosity, yield, thicken, solidify, or provide solid or crystalline structure to the personal care composition
  • soluble means at least about 0.1 g of solute dissolves in 100 ml of solvent, at 25 °C and 1 aim of pressure.
  • the personal care composition includes a di-amido gellant.
  • the di-amido gellant may serve as a structurant in the personal care composition.
  • the personal care composition may comprise from about 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, 1 %, 2.5%, 5%, 7.5%, or 10% to about 30%, 25%, 20%, 15%, 10%, 5%, 3%, 2%, 1 %, or 0.5% of the di-amido gellant.
  • the di-amido gellant may be used in an aqueous phase including water and/or water soluble solvents.
  • the di-amido gellant may be used in an oil phase including oils described herein.
  • the di-amido gellant comprises at least two nitrogen atoms, wherein at least two of said nitrogen atoms form amido functional substitution groups.
  • the amido groups are different.
  • the amido functional groups are the same.
  • the di- amido gellant has the following formula:
  • R i and R 2 re aminofunctional end-groups which may be the same or different and L is a linking moiety of molecular weight from 14 to 500 g/mol.
  • Aminofunctional end-groups include amino or amido groups. Suitable aminofunctional end-groups are exemplified in greater detail below.
  • R i is R3 or
  • AA is selected from the group consisting of:
  • R3 and R4 independently have the formula:
  • (m + q) is from 1 to 10, such that R
  • L has the formula:
  • L', L" from formula [II] and A, B, C, D from formula [III] are independently selected from the group consisting of:
  • R, R' and R" are independently selected from the group consisting of:
  • ein r is an integer from 1 to 20 and Y + is a cation.
  • R, R' and R" are independently selected from the group consisting of
  • the di-amido gellant is characterized in that L is an al iphatic linking group with a backbone chain of from 2 to 20 carbon atoms, such as -(CH2) n - wherein n is selected from 2 to 20, and Ri and R2 both have the formula:
  • AA is selected from the group consisting of: or from the group consisting of:
  • R is selected from the group:
  • R, R', and R" can independently be selected from the group consisting of: an ethoxy group, an epoxy group with 1 to 15 ethoxy or epoxy units.
  • the R, R' and R" may comprise a functional end group selected from the group consisting of: an aromatic, alicyclic, heteroaromatic, heterocyclic group including mono-, di-, and oligo-polysaccharides.
  • L may be selected from C2 to C20, C6 to C I 2, or C8 to CIO hydrocarbyl chain.
  • the di-amido gellant may have a molecular weight from 150 to 1500 g/mol, from 300 g mol to 900 g mol, or from 400 g/mol to 700 g/mol.
  • two or more of L, L' and L" are the same group.
  • the di-amido gellant molecule can be symmetric with respect to the L entity or can be asymmetric. Without intending to be bound by theory, it is believed that symmetric di-amido gellant molecules allow for more orderly structured networks to form whereas compositions comprising one or more asymmetric di-amido gellant molecules can create disordered networks. The types of interactions between the di-amido gellant molecules are described in detail hereinafter.
  • the AA comprises at least one of: Alanine, ⁇ -Alanine and substituted Alanines; Linear Amino-Alkyl Carboxylic Acid; Cyclic Amino-Alkyl Carboxylic Acid; Aminobenzoic Acid Derivatives; Aminobutyric Acid Derivatives; Arginine and Homologues; Asparagine; Aspartic Acid; p-Benzoyl-Phenylalanine; B iphenylalanine; Citrulline; Cyclopropylalanine; Cyclopentylalanine; Cyclohexylalanine; Cysteine, Cystine and Derivatives; Diaminobutyric Acid Derivatives; Diaminopropionic Acid; Glutamic Acid Derivatives; Glutamine; Glycine; Substituted Glycines; Histidine; Homoserine; Indole Derivatives; Isoleucine; Leucine and Derivatives; Lysine;
  • the molecule may also comprise protective groups, preferably from 1 to 2 protective groups.
  • protective groups preferably from 1 to 2 protective groups. Examples of suitable protective groups are provided in "Protecting Groups", P.J. Kocienski, ISBN 313 1 35601 4, Georg Thieme Verlag, Stutgart; and "Protective Groups in Organic Chemistry", T.W. Greene, P.G.M. Wuts, ISBN 0-471 -62301-6, John Wiley& Sons, Inc, New York.
  • the di-amido gellant is a thermoreversible gellant such as described in US Patent 7,332,529.
  • An example of this molecule is provided below:
  • each R is C9 to C 12 alkyl, provided that when X is C6 alkylene, each R must be C I O alkyl.
  • each R is C I O alkyl.
  • each R is C I O alkyl and X is C6 or C 12 alkylene.
  • each R is C I 2 alkyl.
  • each R is C 12 alkyl and X is C I 2 alkylene.
  • the di-amido gellant preferably may have a minimum gelling concentration (MGC) of from about 0.1 mg/mL or 0.5 mg/mL to about 100 mg/mL, 25 mg/mL, or l Omg/mL in the personal care composition, in accordance with the MGC Test Method.
  • MGC minimum gelling concentration
  • the MGC as used herein can be represented as mg/ml or as a wt %, where wt% is calculated as the MGC in mg/ml divided by 10.
  • the MGC is at least 0.1 mg/mL, at least 0.3 mg/mL, at least 0.5 mg/mL, at least 1 .0 mg/mL, at least 2.0 mg/mL, at least 5.0 mg/mL of di- amido gellant.
  • Tables 1 -3 exemplify particular di-amido gellants suitable for use in a personal care composition:
  • Table 2 Non-limiting examples of di-amido gellants of use in a personal care composition dibenzyl (2S,2'S)-1 , 1 '-(ethane- 1 ,2- dibenzy 1 (2S ,2'S)- 1 , 1 '-(propane- 1 ,3- diylbis(azanediyl))bis(3-methyl- 1 -oxobutane-2, 1 - diylbis(azanediyl))bis(3-methyl- 1 -oxobutane-2, 1 - diyl)dicarbamate diyl)dicarbamate
  • the personal care composition may comprise a mixture of two or more di-amido gellant structurants.
  • a mixture may include di-amido gellant structurants with differing solubilites in the carrier or solvent to be structured.
  • the personal care composition may be a skin care, anti-perspirant, deodorant, cosmetic, or hair care product.
  • the personal care composition may be used as, for example, a moisturizer, conditioner, anti-aging compound, skin lightener, sunscreen, sunless tanner, shave preparation, lipstick, foundation, mascara, after-shave, and combinations thereof.
  • the composition is applied to the face, neck, hands, arms, and other typically exposed areas of the body.
  • the personal care composition may involve a wide variety of forms. Non-limiting examples include simple solutions (e.g. , water or oil based), dispersions, and emulsions.
  • the personal care composition may be substantially anhydrous. "Substantially anhydrous” means that the composition comprises no more than about 1 %, 0.5%, or, 0% water.
  • the personal care compositions may be fluid or solid (gels, sticks, flowable solids, amorphous materials).
  • the personal care composition is in the form of an emulsion. Emulsion may be generally classified as having a continuous aqueous phase (e.g. , oil-in-water and water- in-oil-in-water) or a continuous oil phase (e.g. , water-in-oil and oil-in-water-in-oil).
  • the personal care composition has a turbidity of from about 5 NTU to less than about 3000 NTU, 1000 NTU, 500 NTU, or 100 NTU.
  • the personal care composition may be in a form comprising at least one discrete, visually distinct first phase and at least one discrete, visually distinct second phase.
  • “visually distinct” means that the phases can be separately seen by the human eye as distinctly separate regions (i.e. , not emulsions or dispersions of particles.
  • at least one phase forms a stable pattern, for example a continuous or discontinuous line, a spiral, a curve, or other geometric shape, within a transparent phase, where "within” means that one phase is substantially surrounded by the other phase the and does not contact the side of a container.
  • the phases may form a swirled pattern, wherein both phases alternately contact the side of a container and wherein the width of each of phase, when viewed through the side of a transparent container, is substantially constant, but may differ from each other.
  • the phases may form a marbled pattern, wherein the phases alternately contact the side of the container and wherein the width of the individual phases, when viewed through the side of a transparent container, may vary throughout the composition.
  • the first phase is a transparent, clear or translucent aqueous phase and the second phase is either an opaque white or colored non-aqueous phase.
  • at least one aqueous phase forms a pattern within a non-aqueous phase.
  • composition optionally may comprise a three or more visually distinct and stable phases. Discrete, visually distinct multi-phase compositions are described in U.S. Patent Application Publication Nos. 2007/0297996, 2004/0057920, and 2004/02191 19.
  • the personal care composition may comprise a carrier.
  • Carriers may be selected for various stability, aesthetics, and/or compatibility with other materials present in the personal care composition.
  • Suitable carriers include water and/or water soluble solvents.
  • the personal care composition may comprise from about 1 % to about 95 % by weight of water and/or water- equivalent solvent.
  • the composition may comprise from about 1 %, 3%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, or 90% to about 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 10% , or 5% water and/or a water-equivalent solvent.
  • Water-equivalent solvent refers to a compound which has a similar ability as water to solubilize a material.
  • Suitable water-equivalent solvents include monohydric alcohols, clihydric alcohols, polyhydric alcohols, glycerol, glycols, polyalkylenc glycols such as polyethylene glycol, and mixtures thereof.
  • Particularly suitable solvents include lower aliphatic alcohols such as ethanol, propanol, butanol, isopropanol; diols such as 1 ,2-propanediol, 1 ,3-propanediol, butanediol, pentanediol, hexanediol, heptanediol, decanediol; glycerin; water, and mixtures thereof.
  • the personal care composition comprises water, diols, glycerin, and combinations thereof.
  • Suitable carriers also include oils.
  • the personal care composition may comprise from about 1 % to about 95 % by weight of one or more oils.
  • the composition may comprise from about 1 %, 3%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, or 90% to about 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, 40%, 35%, 30%, 25%, 20%, 15%, 10%, or 5% of one or more oils.
  • Oils may be used to solubilize, disperse, or carry materials that are not suitable for water or water-equivalent solvents.
  • Suitable oils include silicones, hydrocarbons, esters, fatty amides, ethers, and mixtures thereof. Oils may be fluid at room temperature. However, certain personal care product forms (i.e. , solid or semi- solid stick) may require non-fluid oils.
  • the oils may be volatile or nonvolatile. "Non-volatile” means a material that exhibits a vapor pressure of no more than about 0.2 mm Hg at 25°C at one atmosphere and/or a material that has a boiling point at one atmosphere of at least about 300°C. "Volatile” means that the material exhibits a vapor pressure of at least about 0.2 mm. of mercury at 20° C. Volatile oils may be used to provide a lighter feel when a heavy, greasy film is undesirable.
  • Suitable oils include volatile oils.
  • the volatile oils may have a viscosity ranging from about 0.5 to about 5 centistokes 25°C.
  • Volatile oils may be used to promote more rapid drying of the skin care composition after it is applied to skin.
  • Nonvolatile oils are also suitable for use in the composition.
  • Nonvolatile oils are often used for emolliency and protective properties.
  • Nonvolatile oils preferably may have a viscosity ranging from about 5 to about 800,000 est (or greater) or from about 20 to about 200,000 est.
  • Suitable silicone oils include polysiloxanes.
  • Polylsiloxanes may have a viscosity of from about 0.5 to about 1 ,000,000 centistokes at 25°C.
  • Such polysiloxanes can be represented by the general chemical formula:
  • R is independently selected from hydrogen or Cuo straight or branched chain, saturated or unsaturated alkyl, phenyl or aryl, trialkylsi loxy; and x is an integer from 0 to about 10,000, chosen to achieve the desired molecular.
  • R is hydrogen, methyl, or ethyl.
  • Commercially available polysiloxanes include the polydimethylsiloxanes, which are also known as dimethicones, examples of which include the DM-Fluid series from Shin-Etsu, the Vicasil ® series sold by Momentive Performance Materials Inc., and the Dow Corning ® 200 series sold by Dow Corning Corporation.
  • suitable polydimethylsiloxanes include Dow Corning® 200 fluids (also sold as Xiameter® PMX-200 Silicone Fluids) having viscosities of 0.65, 1 .5, 50, 100, 350, 10,000, 1 2,500 100,000, and 300,000 centistokes.
  • Suitable dimethicones include those represented by the chemical formula:
  • R and R are each independently hydrogen or C1.30 straight or branched chain, saturated or unsaturated alkyl, aryl, or trialkylsiloxy; and x and y are each integers of 1 to 1 ,000,000 selected to achieve the desired molecular weight.
  • Suitable silicones include phenyl dimethicone (BotansilTM PD- 151 from Botanigenics, Inc.), diphenyl dimethicone (KF-53 and F-54 from Shin-Etsu), phenyl trimethicone (556 Cosmetic Grade Fluid from Dow Corning), or trimethylsiloxyphenyl dimethicone (PDM-20, PDM-200, or PDM- 1000 from Wacker-Belsil).
  • alkyl dimethicones wherein at least R' is a fatty alkyl (e.g. , Ci 2 . 2 2).
  • a suitable alkyl dimethicone is cetyl dimethicone, wherein R' is a straight C16 chain and R is methyl. Cetyl dimethicone, is available as s 2502 Cosmetic Fluid from Dow Corning or as Abil Wax 9801 or 9814 from Evonik Goldschmidt GmbH.
  • Cyclic silicones are one type of silicone oil that may be used in the composition. Such silicones have the general formula:
  • a mixture of cyclomethicones is used where n is 4, 5, and/or 6.
  • silicone oils suitable for use in the personal care composition include polymers having the general formula:
  • R 1 is hydrogen, phenyl, hydroxy, or C
  • R 2 is hydrogen, phenyl or a yl, or a saturated hydrocarbon radical, preferably an a!kyl radical from about C
  • An exemplary silicone polymer is trimethylsilylamodimethicone as shown in the following formula:
  • Another exemplary silicone polymer is represented by the general formula:
  • R 3 is a monovalent hydrocarbon radical from Ci to Cig, preferably an alkyl or alkenyl, such as methyl;
  • R is a hydrocarbon, preferably a C] to C) 8 alkylene or a Ci 0 to Ci 8 alkyleneoxy, more preferably a Ci to C 8 alkyleneoxy;
  • Q " is a halide ion, preferably chloride;
  • r is an average statistical value from 2 to 20, preferably from 2 to 8;
  • s is an average statistical value from 20 to 200, preferably from 20 to 50.
  • a suitable polymer of this class is known as UCARE SILICONE ALE 56TM, available from Union Carbide.
  • Other suitable silicone materials are disclosed in US Patent Application Publication No. 2007/0039103 A l .
  • Suitable hydrocarbon oils include straight or branched chain alkanes and alkenes. The chain length may be selected based on desired functional characteristics such as volatility. Suitable hydrocarbon oils may have between 5-20 carbon atoms or, alternately, between 8-16 carbon atoms. Suitable hydrocarbons include pcntane, hexane, heptane, decane, dodecane, tetradecane, tridecane, and Cs-2o isoparaffins as disclosed in U.S. Pat. Nos. 3,439,088 and 3,818, 105.
  • Suitable hydrocarbons include isooctane, isododecane, isohexadecane, isoeicosane by Permethyl Corporation under the tradename Permethyl®.
  • Suitable hydrocarbon oils may have greater than about 20 carbon atoms. Examples of such hydrocarbon oils include C24-28 olefins, C30-45 olefins, C2 0 -40 isoparaffins, hydrogenated polyisobulene, polyisobutene, polydecene, hydrogenated polydecene, mineral oil, pentahydrosqualene, squalene, squalane, and mixtures thereof.
  • esters typically contain at least 10 carbon atoms. These esters include esters with hydrocarbyl chains derived from fatty acids or alcohols (e.g. , mono-esters, polyhydric alcohol esters, and di- and tri-carboxylic acid esters). The hydrocarbyl radicals of the esters hereof may include or have covalently bonded thereto other compatible functionalities, such as amides and alkoxy moieties (e.g. , ethoxy or ether linkages, etc.).
  • esters include, but are not limited to, isopropyl isostearate, hexyl laurate, isohexyl laurate, isohexyl palmitale, isopropyl palmitate, decyl oleate, isodecyl oleate, hexadecyl siearate, decyl stearate, isopropyl isostearate, dihexyldecyl adipate, lauryl lactate, myristyl lactate, cetyl lactate, oleyl stearate, oleyl oleate, oleyl myristate, lauryl acetate, cetyl propionate, and oleyl adipate.
  • Other suitable esters are further described in the Personal Care Product Council's International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition, 2010, under the functional category of "Esters.”
  • esters suitable for use in the personal care composition include mono-carboxylic acid esters of the general formula R'COOR, wherein R' and R are straight or branched chain, saturated or unsaturated alkyl, aryl, and wherein sum of carbon atoms in R' and R is at least 10,
  • a suitable monoester is alkyl benzoate such as C I 2- 15 alkyl benzoate.
  • esters suitable for use in the personal care composition include di- and tri-alkyl and alkenyl esters of carboxylic acids, such as esters of C4 to C « dicarboxylic acids (e.g. C
  • di- and tri- alkyl and alkenyl esters of carboxylic acids include isocetyl stearyol stearate, diisopropyl adipate, dibutyl adipate, and tristearyl citrate.
  • esters suitable for use in the personal care composition include those known as polyhydric alcohol esters.
  • Such polyhydric alcohol esters include alkylene glycol esters, such as ethylene glycol mono and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty acid esters, ethoxylated glyceryl monostearate, 1 ,3-butylene glycol monostearate, 1 ,3-butylene glycol distcarate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxy- ethylene sorbitan fatty acid esters.
  • esters suitable for use in the personal care composition include glycerides, including, but not limited to, mono-, di-, and tri-glycerides.
  • the glycerides may be mono-, di-, and tri-esters of glycerol and long chain carboxylic acids, such as Cio to C22 carboxylic acids.
  • a variety of these types of materials can be obtained from vegetable and animal fats and oils, such as castor oil, safflower oil, cottonseed oil, corn oil, olive oil, cod liver oil, almond oil, avocado oil, palm oil, sesame oil, sweet almond oil, apricot kernel oil, camelina sativa oil, rapeseed oil, tamanu seed oil, linseed oil, coconut oil, lanolin oil, soybean oil, and the like.
  • Synthetic oils include, but are not limited to, triolein and tristearin glyceryl dilaurate.
  • glyceryl esters of fatty acids include fatty acid mono-, di-, and triglycerides which are natural fats or oils that have been modified such as glyceryl stearate, diglyceryl diiosostearate, polyglyceryl-3 isostearate, polyglyceryl-4 isostearate, polyglyceryl-6 ricinoleate, glyceryl dioleate, glyceryl diisotearate, glyceryl tetraisostearate, glyceryl trioctanoate, diglyceryl distearate, glyceryl linoleate, glyceryl myristate, glyceryl isostearate, PEG castor oils, PEG glyceryl oleates, PEG glyceryl stearates, PEG glyceryl tallowates, and the like.
  • Suitable oils include fatty amides.
  • Fatty amides include compounds having an amide functional group while being liquid at 25 °C and insoluble in water.
  • the fatty amide may have the general formula:
  • R l is an optionally functionalized, aliphatic, cycloaliphatic or cyclic, saturated or unsaturated, monovalent hydrocarbon radical containing from 1 to 30 carbon atoms (alternately, from 1 to 22 carbon atoms);
  • R2, R3 and R4, which may be identical or different, are hydrogen or optionally functionalized, aliphatic, cycloaliphatic or cyclic, saturated or unsaturated, monovalent hydrocarbon radicals containing from 1 to 30 carbon atoms, preferably from 1 to 22 carbon atoms; r is 0 or 1 ; q is an integer from 0 to 2; and p equals 0 or 1 .
  • Particular fatty amides include N-acetyl-N-butylaminopropionate, isopropyl N-lauroylsarcosinate, and N, ,-diethyltoluamide.
  • Other suitable fatty amides are disclosed in U.S. Patent No. 6,872,401.
  • Other suitable oils include ethers.
  • Suitable ethers include saturated and unsaturated fatty ethers of a polyhydric alcohol, and alkoxylatcd derivatives thereof.
  • Exemplary ethers include C4- 2 0 alkyl ethers of polypropylene glycols, and di-Cg.30 alkyl ethers. Suitable examples of these materials include PPG- 14 butyl ether, PPG- 15 stearyl ether, dioctyl ether, dodecyl octyl ether, and mixtures thereof.
  • the personal care composition may comprise an emulsifier.
  • An emulsifier is particularly suitable when the composition is in the form of an emulsion or if immiscible materials are being combined.
  • the skin care composition may comprise from about 0.05%, 0. 1 %, 0.2%, 0.3%, 0.5%, or 1 % to about 20%, 10%, 5%, 3%, 2%, or 1 % emulsifier.
  • Emulsifiers may be nonionic, anionic or cationic. Non-limiting examples of emulsifiers are disclosed in U.S. Patent 3,755,560, U.S. Patent 4,421 ,769, and cCutcheon's, Emulsifiers and Detergents, 2010 Annual Ed., published by M. C.
  • Suitable emulsifiers are further described in the Personal Care Product Council's International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition, 2006, under the functional category of "Surfactants - Emulsifying Agents.”
  • Suitable emulsifying ethers and esters include:
  • Ethers of polyglycols and of fatty alcohols - including saturated or unsaturated Cn-30 alcohols (e.g., oleyl alcohol, cetyl alcohol, stearyl alcohol or behenyl alcohol) and polyglycols comprising n number of oxyalkylene groups wherein n an integer from 1 to 200 or, alternately, from 2 to 30 (e.g. , 1 to 20 oxyethylene groups).
  • Particular examples include compounds with the INCI names of slearefh-H, beheneth-n or oleth-/z.
  • Suitable examples include compounds having the INCI names steareth-8, steareth- 10, stearelh- 16, steareth-20, ceteth- 10, laureth-4, laureth-3, trideceth-6, ceteareth-5, oleth- 10, and beneth- 10.
  • Esters of polyglycols and of fatty acids - including saturated or unsaturated C12-30 fatty acids (e.g. , oleic acid, cetylic acid, stearic acid) and polyglycols comprising n number of oxyalkylene groups wherein n an integer from 1 to 200 or alternately, 1 to 50 (e.g. , 1 to 20 oxyethylene groups).
  • Particular examples include compounds with the INCI name VEG-n stearate or PEG-n oleate).
  • Suitable examples include polyethylene glycol-8 monostearate, polyethylene glycol- 10, or polyethylene glycol- 12 distearatc.
  • Ethers of polyglycols and of fatty alcohols which are glycosylated - including C12-30 alcohols having from 1 to 10 glycosyl groups and polyglycols comprising n number of oxyalkylene groups wherein n an integer from 1 to 200 (e.g. , 1 to 20 oxyethylene groups).
  • Esters of C 1 -30 fatty acids and of glycerol or of polyglycerol - including esters comprising from 1 to 10 glycerol groups include hexa-glyceryl monosterate, diglyceryl distearate, tetraglyceryl tristearate, decaglyceryl decastearate, diglyceryl monostearate, hexaglyceryl tristearate, decaglyceryl pentastearate, the ester of glycerol and of palmitic and stearic acids, and glyceryl mono- and dibehenate.
  • Ethers of oxyalkylene-modified C12-30 alcohols and of glycerol or polyglycerol are Ethers of oxyalkylene-modified C12-30 alcohols and of glycerol or polyglycerol.
  • Ethers of C12-30 fatty alcohols comprising and of sucrose or glucose - Suitable examples include compounds with the I NCI names of C I 2- 18 alkylglucoside, C12-20 alkylglucoside (e.g. , Montanov L from Seppic), cetearyl glucoside (e.g. , a mixture with cetearyl alcohol under the reference Montanov 68 from Seppic), myristyl glucoside (e.g. , a mixture with myristyl alcohol under the reference Montanov 14 from Seppic) or cetearyl glucoside (e.g., Tegocare CG 90 from Evonik Goldschmidt),
  • cetearyl glucoside e.g., Tegocare CG 90 from Evonik Goldschmidt
  • Esters of sucrose and of C 12-30 fatty acids include sucrose distearate or sucrose tristearate, sucrose cocoate, sucrose dilaurate, sucrose distearate, sucrose hexaerucate, sucrose hexapalmitate, sucrose laurate, sucrose mortierellate, sucrose myristate, sucrose oleatc, sucrose palmitate, sucrose pentaerucate, sucrose polybehenate, sucrose polycottonscedale, sucrose polylaurate, sucrose polylinoleate, sucrose polyoleate, sucrose polypalmate, sucrose polysoyate, sucrose polystearate, sucrose ricinoleale, sucrose stearate, sucrose tetraisostearate, and sucrose trilauratc.
  • a suitable example includes the mixture of esters (mono- and polyesters) of stearic acid and of sucrose sold as Crodesta Fl 10 by Croda.
  • Esters of pentaerythritol and of C 12.30 fatty acids include pentaerythritol tetrastearate.
  • Esters of sorbitol and/or of sorbitan and of C 12-30 fatty acids include sorbitan monostearate, sorbitan tristearate, or sorbitan laurate, such as Span 20 from Uniqema, Ethers of sorbitol and/or of sorbitan and of alkoxylated sorbitan- Suitable examples include sorbeth-8 beeswax or sorbeth-20 beeswax from Nikko Chemical.
  • Ethers of polyglycols and of cholesterol - Particular examples include choleth-3, choleth- 10 (such as Emalex CS- 10 from Nihon Emulsion Company), choleth- 15 (such as Emalex CS- 15 from Nihon Emulsion Company) or choleth-20 (such as Emalex CS-20 from Nihon Emulsion Company).
  • Esters of C] 2 -3o fatty acids and of alkoxylated ethers of sorbitol and/or of Suitable examples include polysorbate-60, polysorbate-61 , sorbeth-3 isostearate, polyoxyethylenated 4 OE sorbitan monostearate, and polyoxyethylenated 20 OE sorbitan tristearate.
  • Linear or branched type silicone emulsifiers may also be used.
  • Particularly useful polyether modified silicones include KF-601 1 , KF-6012, KF-6013, KF-6015, KF-6015, KF- 6017, KF-6043, KF-6028, and KF-6038 from Shin Etsu.
  • Also particularly useful are the polyglycerolated linear or branched siloxane emulsifiers including KF-61 00, KF-6104, and KF- 6105 from Shin Etsu.
  • Exemplary materials include materials with the following International Nomenclature of Cosmetic Ingredients (INCI) designations: Bis-Butyldimethicone Polyglyceryl- 3; Bis-PEG/PPG- 14/14 Dimethicone; Bis-butyldimethicone Polyglyceryl-3; Bis-isobutyl PEG/PPG- 10/7 Dimethicone copolymer; Bis- PEG/PPG- 18/6 Dimethicone; Bis-PEG/PPG-20/20 Dimethicone; Bis-PEG/PPG- 16/16 PEG/PPG-16/16 Dimethicone; Bis(PPG-7 Undeceneth-21 - Dimethicone; Cetyl Dimethicone PEG-7 Acetate; Cetyl PEG-8 Dimethicone; Cetyl PEG/PPG- 15/16 Butyl Ether Dimethicone; Cetyl .
  • ICI International Nomenclature of Cosmetic Ingredients
  • Emulsi fiers also include emulsifying silicone elastomers.
  • Suitable emulsifying silicone elastomers may include at least one polyalkyl ether or polyglycerolated unit. These cross-linked elastomers may also be co-modified to include alkyl substituents. Suitable formation techniques are described in U.S. Pat. Nos. 5,236,986; 5,412,004; 5,837,793 ; and 5,81 1 ,487.
  • Polyoxyalylenated emulsifying silicone elastomers that may be used in at least one embodiment of the invention include those sold by Shin-Etsu Silicones under the names KSG-21 , KSG-20, KSG-30, SG-3 1 , KSG-32, KSG-33; KSG-210 (dimethicone/PEG- 10/15 crosspolymer dispersed in dimethicone); SG-310 (PEG- 15 lauryl dimethicone crosspolymer); KSG-320 (PEG- 15 lauryl dimethicone crosspolymer dispersed in isododecane); KSG-330 (PEG- 15 lauryl dimethicone crosspolymer dispersed in triethylhexanoin), KSG-340 (PEG- 10 lauryl dimethicone crosspolymer and PEG- 15 lauryl dimethicone crosspolymer).
  • silicone emulsifying elastomers are supplied by Dow CorningTM, including PEG- 12 dimethicone crosspolymers (DC 9010 and 901 1 ).
  • suitable silicone emulsifiers sold by Dow Corning include DC9010 and DC901 1.
  • Polyglycerolated emulsifying silicone elastomers are disclosed in PCT/WO 2004/024798.
  • Such elastomers include Shin-Etsu's KSG series, such as KSG-710 (dimethicone/polyglycerin-3 crosspolymer dispersed in dimethicone); or lauryl dimethicone/polyglycerin-3 crosspolymer dispersed in a variety of solvent such as isododecane, dimethicone, triethylhexanoin, available as KSG-810, SG-820, KSG-830, or KSG-840 from Shin-Etsu.
  • Another suitable crosslinked silicone elastomer emulsifier is dimethicone/PEG- 10/15 crosspolymer, which provides excellent aesthetics due to its elastomeric backbone, but also excellent emulsification properties.
  • Further examples of crosslinked organosiloxane emulsifiers include, but are not limited to dimethicone/dimethicone PEG/PPG 15 crosspolymer; dimethicone PEG-10 crosspolymer; dimethicone PEG- 10/15 crosspolymer; dimethicone PEG- 15 crosspolymer; dimethicone polyglycerin-3 crosspolymer; dimethicone PPG-20 crosspolymer; lauryl dimethicone PEG- 1 5 crosspolymer; lauryl dimethicone polyglycerin-3 crosspolymer; PEG-8 dimethicone polysorbate-20 crosspolymer; PEG- 10 dimethicone/vinyl dimethicone crosspolymer
  • silicone elastomers may be supplied pre-swollen with a solvent.
  • the weight percentages recited for emulsifier use i.e. , from about 0.05% to about 20%, from about 0.1 % to about 10%, from about 0.5% to about 5%, or from about 1 % to about 3% emulsifier
  • the weight percentages recited for emulsifier use are of the elastomer alone (i.e., excluding the weight of the solvent).
  • the personal care composition may comprise structuring agent in addition to the di-amido gellant described above.
  • Structuring agents may be used to increase viscosity, thicken, solidify, or provide solid or crystalline structure to the personal care composition.
  • Structuring agents are typically grouped based on solubility, dispersibility, or phase compatibility.
  • aqueous or water structuring agents include polymeric agents, natural or synthetic gums, polysaccharides, and the like.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, 1 %, 2%, 3%, 5% to about 25%, 20%, 10%, 7%, 5%, 4%, or 2%, by weight of the composition, of one or more structuring agents.
  • Polysaccharides and gums may be used as aqueous phase thickening agents.
  • examples of such polysaccharides and gums include naturally derived materials such as agar, agarose, alicaligenes polysaccharides, algin, alginic acid, acacia gum, amylopectin, chitin, dextran, cassia gum, cellulose gum, gelatin, gellan gum, hyaluronic acid, hydroxyethyl cellulose, methyl cellulose, ethyl cellulose, pectin, sclerotium gum, xanthan gum, pectin, trehelose, gelatin, ammonium alginate, calcium alginate, calcium carrageenan, carnitine, carrageenan, guar gum, guar hydroxypropyltrimonium chloride, hyaluroinic acid, hydroxypropyl chitosan, hydroxypropyl guar, karaya gum,
  • Suitable polysaccharides include alkyl hydroxyalkyl cellulose ethers such as cetyl hydroxyethylcellulose, which is the ether of cetyl alcohol and hydroxyethylcellulose. This material is sold under the tradename Natrosol® Plus CS from Ashland Aqualon Functional I ngredients.
  • Other useful polysaccharides include scleroglucans comprising a linear chain of ( 1 -3) linked glucose units with a ( 1 -6) linked glucose every three units, a commercially available example of which is ClearogelTM CS 1 1 from .M.P., Inc.
  • Suitable classes of polymeric structuring agents include but are not limited to carboxylic acid polymers, polyacrylamide polymers, sulfonated polymers, high molecular weight polyalkylglycols or polyglycerins, copolymers thereof, hydrophobically modified derivatives thereof, and mixtures thereof.
  • Carboxylic acid polymers include carbomers. These polymers are crosslinked compounds containing one or more monomers derived from acrylic acid, substituted acrylic acids, and salts and esters of these acrylic acids and the substituted acrylic acids, wherein the crosslinking agent contains two or more carbon-carbon double bonds and is derived from a polyhydric alcohol.
  • Suitable materials includes include the Carbopol ® 900 series (e.g.
  • Other suitable carboxylic acid polymeric agents include copolymers of C
  • C alcohol esters wherein the crosslinking agent is an allyl ether of sucrose or pentaerytritol.
  • crosslinking agent is an allyl ether of sucrose or pentaerytritol.
  • copolymers are known as acrylates/Cio.30 alkyl acrylate crosspolymers and are commercially available as Carbopol ® 1 342, Carbopol ® 1382, PEMULENTM TR-1 , and PEMULENTM TR-2, from Noveon, Inc.
  • Sulfonated polymers include polymers and copolymers containing 2-acrylamido-2- methylpropane sulfonic acid (i.e. , AMPS or acryloyldimcthyl tauric acid) and salts thereof.
  • 2-acrylamido-2- methylpropane sulfonic acid i.e. , AMPS or acryloyldimcthyl tauric acid
  • Exemplary AMPS structurants include sodium acrylate/sodium acryloyldimcthyl taurate copolymer available as SIMULGEL® EG and SIMULGEL® EPG or hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer available as SIMULGEL® NS, SIM ULGEL® FL, and SIMULGEL ® I-NS 100; which are available from Seppic Corporation (Fairfield, N.J .).
  • Another suitable sulfonated polymer is sodium polyacryloyldimethyl taurate available as Simul gel ® 800 f rom Seppic Corporation (Fairfield, N.J.).
  • Suitable sulfonated polymers include acrylamide/sodium acryloyldimcthyltaurate/acrylic acid copolymer available as AcudyneTM SCP from Rohm and Haas Company, Inc.; acrylamide/sodium acryloyldimethyltaurate copolymer available as Simulgel ® 600 from Seppic; ammonium acryloyldimethyltaurate/beheneth-25 methacrylate crosspolymer avilable as Aristoflex® BLV from Clariant International Ltd.
  • dimethylacrylamide/sodium acryloyldimethyltaurate crosspolymer available as S Upolymer G- l from Toho Chemical Industry Co., Ltd.
  • sodium acrylate/acryloyldimethyltauratc/dimethylacrylamide crosspolymer available as SepinovTM P88 from Seppic
  • sodium acryloyldimethyltauratc/VP Crosspolymer available as Aristoflex® AVS from Clariant International, Ltd.
  • Additional sulfonated structurants are described in US Patent Application Publicaiton Nos.
  • 2007/0140993 (identified as gelling agent in the form of a copolymer of acryloyl dimethyl tauric acid or a salt thereof) and 2006/0147396 A l (identified as "polymer containing at least one sulpho- unctional monomer").
  • Acrylamide polymers and copolymers include SEP1GEL® 305 from Seppic Corporation (Fairfield, N.J.), which is designated by the Personal Care Product Council's international Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition, 2010, as "polyacrylamide and isoparaffin and laureth-7.”
  • Other polyacrylamide polymers include multi-block copolymers of acrylamides and substituted acrylamides with acrylic acids and substituted acrylic acids.
  • Commercially available examples of these multi-block copolymers include HYPAN® SR 150H, SS500V, SS500 W, SSSA 100H, from Lipo Chemicals, Inc., (Patterson, N.J .).
  • High molecular weight polyalkylglycols or polyglycerins may be used as structuring agents.
  • Suitable materials include polyethylene glycols (PEG) derivatives and polypropylene glycols (PPG) derivatives with an n degree of polymerization, n may be from 50 to 200,000.
  • Other suitable materials are polyglycerins having repeating glycerin moieties where the number of repeating moieties ranges from about 15 to about 200, or from about 20 to about 100. Examples of suitable polyglycerins include those having the INCI names polyglycerin-20, polyglycerin-40, and the like.
  • oil structuring agents examples include silicone and organic based materials. Suitable ranges of oi l structuring agents are from about 0.01 %, 0.05%, 0. 1 % 0.5%, 1 %, 2.5%, 5%, or 10% to about 30%, 25%, 20%, 15%, 10%, or 5%.
  • Suitable oil phase structuring agents may be silicone based, such as silicone elastomers, silicone gums, silicone waxes, linear silicones having a degree of polymerization allowing the silicone to increase the viscosity of the oil phase. Examples of silicone structuring agents include, but are not limited to, silicone elastomers, silicone gums, and silicone waxes,
  • Silicone elastomers suitable for use in the compositions of the invention include those that are formed by addition reaction-curing, by reacting an SiH-containing diorganosiloxane and an organopolysi loxane having terminal olefinic unsaturation, or an alpha-omega diene hydrocarbon, in the presence of a platinum metal catalyst.
  • Such elastomers may also be formed by other reaction methods such as condensation-curing organopolysiloxane compositions in the presence of an organotin compound via a dehydrogenation reaction between hydroxyl-terminated diorganopolysiloxane and Si H-containing diorganopolysiloxane or alpha omega diene; or by condensation-curing organopolysiloxane compositions in the presence of an organotin compound or a titanate ester using a condensation reaction between an hydroxyl-terminated diorganopolysiloxane and a hydrolysable organosiloxane; peroxide- curing organopolysiloxane compositions which thermally cure in the presence of an organoperoxide catalyst.
  • Suitable silicone elastomers may be in the powder form, or dispersed or solubilized in solvents such as volatile or nonvolatile silicones, or silicone compatible vehicles such as hydrocarbons or esters.
  • silicone elastomer powders include vinyl dimethicone/melhicone silesquioxane crosspolymers like KSP- 100, KSP- 101 , KSP- 102, KSP- 103, KSP- 104, KSP- 105, available from Shin-Etsu, hybrid silicone powders that contain a fluoroalkyl group like KSP-200, available from Shin-Etsu, which is a fluoro-silicone elastomer, and hybrid silicone powders that contain a phenyl group such as KSP-300, available from Shin- Etsu, which is a phenyl substituted silicone elastomer; and DC 9506 available from Dow Corning.
  • silicone elastomer dispersed in a silicone compatible vehicle examples include dimethicone/vinyl dimethicone crosspolymers supplied by a variety of suppliers including Dow Corning Corporation under the tradenames DC9040 or DC9041 , Momentive under the tradename SFE 839, or Shin-Etsu Silicones under the tradenames KSG- 15, 16, 18.
  • KSG- 15 has the INCI name cyclopentasiloxane (and) dimethicone/vinyl dimethicone crosspolymer.
  • KSG- 18 has the INCI name diphenylsiloxy phenyl trimethicone (and) dimethicone/phenyl vinyl dimethicone crosspolymer.
  • Silicone elastomers may also be purchased from Grant Industries under the Gransil trademark.
  • Other suitable silicone elastomers have long chain alkyl substitutions such as lauryl dimethicone/vinyl dimethicone crosspolymers supplied by Shin Etsu under the tradenames KSG-3 1 , KSG-32, KSG-41 , KSG-42, KSG-43, and KSG-44.
  • Silicone gums are another oil phase structuring agent.
  • the silicone gum typically has a viscosity ranging from about 500,000 to 100 million est at 25° C, from about 600,000 to 20 million, from about 600,000 to 12 million est.
  • the silicone gums that are used in the compositions include, but are not limited to, those of the general formula wherein:
  • Ri to Rio are each independently hydrogen, an alkyl having 1 to 30 carbon atoms, aryl, or aralkyl; and X is H, OH, or a C l -30 alkyl or vinyl, x, y, or z may be zero with the proviso that (x + y + z) > 1 .
  • silicone gums may be purchased in pure form from a variety of silicone manufacturers including Wacker-Chemie or Dow Corning, and the like. Silicone gums include those sold by Wacker-Belsil under the trade names CM3092, Wacker-Belsil 1000, or Wacker- Belsil DM 3096. A silicone gum where X is OH, also referred to as dimethiconol, is available from Dow Corning Corporation under the trade name 1 - 1254 Fluid, 2-9023 Fluid, and 2-9026 Fluid. The silicone gum may also be purchased in the form of a solution or dispersion in a silicone compatible vehicle such as volatile or nonvolatile silicone.
  • Such a mixture may be purchased from Bamet Silicones under the HL-88 tradename, having the INCI name dimethicone.
  • Another example is a mixture of dimethiconol and volatile or nonvolatile silicone available from the Dow Corning Corporation as tradename 1401 Fluid, 1403 Fluid, and 1501 Fluid.
  • silicone waxes may be referred to as alkyl silicone waxes which and are semi-solids or solids at room temperature.
  • alkyl silicone wax means a polydimethylsiloxane having a substituted long chain alkyl (such as C 16 to 30) that confers a semi-solid or solid property to the siioxane.
  • examples of such silicone waxes include stearyl dimethicone, which may be purchased from Evonik Goldschmidt GmbH under the tradename Abil Wax 9800 or from Dow Corning under the tradename 2503.
  • Another example is bis-stearyl dimethicone (which may be purchased from Gransil Industries under the tradename Gransil A- 1 8), behenyl dimethicone, or behenoxy dimethicone.
  • Suitable structuring agents include polyamides and polysilicone-polyamide copolymers.
  • Suitable polysilicone-polyamide copolymers are disclosed in U.S. Patent Application Publication No. 2004/0170586.
  • a specific example of such copolymers is nylon 61 1 /dimethicone copolymers by Dow Coming under the tradename Dow Coming 2-8178.
  • polyamides such as those purchased from Arizona Chemical under the UniclearTM and Sylvaclear® including Sylvaclear® A200V or A2614V (INCI name: ethylenediamine/hydrogenated dimer dilinoleate copolymer bis-di-C 14- 18 alkyl amide); Sylvaclear® AF1900V and Sylvaclear® PA 1200V (INCI name: Polyamide-3); Sylvaclear® C75V (INCI name: bis-stearyl ethylenediamine/neopentyl glycol/stearyl hydrogenated dimer dilinoleate copolymer); Sylvaclear ® PE400V (INCI name: Polyamide-6); Sylvaclear ® WF 1500V (INCI name: Polyamidc-4); or UniclearTM 100 VG (INCI name: ethylenediamine/stearyl dimer dilinoleate copolymer; or ethylenediamine/stearyl dim
  • oil phase structuring agents may include one or more natural or synthetic waxes such as animal, vegetable, or mineral waxes. Generally such waxes have a melting point ranging from about 25°C to 125°C, and alternatively from about 30°C to about 100° C.
  • Non-limiting examples of suitable waxes include silicone waxes, fatty esters, for example cetyl and/or stearyl esters, acacia, beeswax, ceresin, flower wax, citrus wax, carnauba wax, jojoba wax, japan wax, polyethylene, microcrystalline, rice bran, lanolin wax, mink, montan, bayberry, ouricury, ozokerite, palm kernel wax, paraffin, avocado wax, apple wax, shellac wax, clary wax, spent grain wax, candelilla, grape wax, polyalkylene glycol derivatives thereof (for example PEG6-20 beeswax, or PEG- 12 carnauba wax) and mixtures of any of the aforementioned waxes.
  • the wax is a polyethylene wax, and alternatively is a polyethylene wax having a melting point of less than 120°C, alternatively less than 95C, and alternatively less than 85°C.
  • Non-limiting examples of suitable silicone waxes are disclosed in U.S. patents 5,413,781 and 5,725,845, and further include alkylmelhyl polysiloxanes, C IO - C60 alkyl dimethicones, and mixtures thereof.
  • the silicone wax may be a C 16-C28 alkyl dimethicone wax.
  • Other suitable silicone waxes include, but are not limited to stearoxydimethicone, behenoxy dimethicone, stearyl dimethicone, cetearyl dimethicone, cetyl dimethicone, and mixtures thereof.
  • Other structuring agents are natural or synthetic montmorillonite minerals such as hectorite, bentonite, and quaternized derivatives thereof, which are obtained by reacting the minerals with a quaternary ammonium compound (e.g., stearalkonium bentonite and stearalkonium hectorite).
  • a quaternary ammonium compound e.g., stearalkonium bentonite and stearalkonium hectorite.
  • silicas, silicates, silica silylate, and alkali metal or alkaline earth metal derivatives thereof are generally found in the particulate form and include silica, silica silylate, magnesium aluminum silicate, and the like.
  • the personal care compositions may comprise one or more optional components to provide an efficacious and/or consumer desirable product.
  • the composition can include other acti ves or agents.
  • suitable optional actives and agents may include an active or agent selected from a group consisting of sugar amines, vitamins, oil control agents, photosterols, hexamidine compounds, tightening agents, anti-wrinkle actives, anti-atrophy actives, flavonoids, N-acyl amino acid compounds, retinoids, peptides, particulate materials, UV actives, photostabilizers, anti-cellulite agents, desquamation actives, anti-acne actives, antioxidants, radical scavengers, conditioning agents, anti-inflammatory agents, tanning actives, skin lightening agents, botanical extracts, antimicrobial actives, antifungal actives, antibacterial actives, antiperspirant actives, sensates, preservatives, anti-dandruff actives, substantivity polymers, deters
  • compositions of the present invention can comprise a sugar amine, which is also known as amino sugar.
  • Sugar amine compounds useful in the present invention can include those described in PCT Publication WO 02/076423 and U.S. Patent No. 6,159,485.
  • the composition may comprise from about 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 10%, 7, 5%, or 2% by weight of the composition, of one or more sugar amine.
  • Sugar amines can be synthetic or natural in origin and can be used as pure compounds or mixtures of compounds (e.g. , extracts from natural sources or mixtures of synthetic materials).
  • glucosamine is generally found in many shellfish and can also be derived from fungal sources.
  • sacchar amine includes isomers and tautomers of such and its salts (e.g. , HC1 salt) and is commercially available from Sigma Chemical Co.
  • sugar amines examples include glucosamine, N-acetyl glucosamine, mannosamine, N-acetyl mannosamine, galactosamine, N-acetyl galactosamine, their isomers (e.g. , stereoisomers), and their salts (e.g., HC1 salt).
  • glucosamine particularly D-glucosamine and N-acetyl glucosamine, particularly N-acetyl-D- glucosamine.
  • the composition may comprise from about 0.001 %, 0.01 %, 0.05%,
  • Vitamins means vitamins, pro-vitamins, and their salts, isomers and derivatives.
  • Non-limiting examples of suitable vitamins include: vitamin B compounds (including B l compounds, B2 compounds, B3 compound, B5 compounds, such as panthenol or "pro-B5", pantothenic acid, pantothenyl; B6 compounds, such as pyroxidine, pyridoxal, pyridoxamine; carnitine, thiamine, riboflavin); vitamin A compounds, and all natural and/or synthetic analogs of Vitamin A, including retinoids, retinol, relinyl acetate, retinyl palmitate, retinoic acid, retinaldehyde, retinyl propionate, carotenoids (pro-vitamin A), and other compounds which possess the biological activity of Vitamin A; vitamin D compounds; vitamin K compounds; vitamin E compounds, or tocopherol, including tocopherol sorbate, tocopherol acetate, other esters of tocopherol and tocopheryl compounds; vitamin C compounds, including ascorbate, ascorbyl esters of
  • vitamin 133 compound means a compound having the formula:
  • R is - CONH2 (i.e. , niacinamide), - COOH (i.e. , nicotinic acid) or - CH20H (i.e. , nicotinyl alcohol); derivatives thereof; and salts of any of the foregoing.
  • CONH2 i.e. , niacinamide
  • COOH i.e. , nicotinic acid
  • CH20H i.e. , nicotinyl alcohol
  • Exemplary derivatives of the foregoing vitamin B3 compounds include nicotinic acid esters, including non-vasodilating esters of nicotinic acid (e.g. , tocopherol nicotinate, myristyl nicotinatc), nicotinyl amino acids, nicotinyl alcohol esters of carboxylic acids, nicotinic acid N- oxide and niacinamide N-oxide.
  • non-vasodilating esters of nicotinic acid e.g. , tocopherol nicotinate, myristyl nicotinatc
  • nicotinyl amino acids e.g., nicotinyl amino acids
  • nicotinyl alcohol esters of carboxylic acids nicotinic acid N- oxide and niacinamide N-oxide.
  • the personal care compositions may comprise one or more oil control agents for regulating the production of skin oil, sebum, or for improving the appearance of oily skin.
  • oil control agents include salicylic acid, dehydroacetic acid, benzoyl peroxide, vitamin B3 compounds, their isomers, esters, salts and derivatives, and mixtures thereof.
  • Dehydroacetic acid i n cludes materials havi ng the formula:
  • Dermatologically acceptable salts include alkali metal salts, such as sodium and potassium; alkaline earth metal salts, such as calcium and magnesium; non-toxic heavy metal salts; ammonium salts; and trialkylammonium salts, such astrimethylammonium and triethylammonium.
  • alkali metal salts such as sodium and potassium
  • alkaline earth metal salts such as calcium and magnesium
  • non-toxic heavy metal salts such as ammonium salts
  • ammonium salts such astrimethylammonium and triethylammonium
  • sodium, potassium, and ammonium salts of dehydroacetic acid may be used.
  • Sodium dehydroacetate is available from Tri-K Industries, Inc., as Tristat SDHA.
  • Derivati ves of dehydroacetic acid include, but are not limited to, any compounds wherein the CII3 groups are individually or in combination replaced by amides, esters, amino groups, alkyls, and alcohol esters.
  • oil control agents include materials capable of absorbing oils and sebum. Suitable oil absorbing materials include starch, calcium silicate, polyethylene, nylon, boran nitride, mica, clays such as bcntonite, montmarrillonitc and kaolin, zeolite, cyclodextrins, fumed silica, synthetic clays such as polymer powders including natural, synthetic, and semisynthetic cellulose, lluorocarbon resins, polypropylene, modified starches of cellulose acetate, particulate cross-linked hydrophobic acrylate or methacrylate copolymers and mixtures thereof.
  • Suitable oil absorbing materials include starch, calcium silicate, polyethylene, nylon, boran nitride, mica, clays such as bcntonite, montmarrillonitc and kaolin, zeolite, cyclodextrins, fumed silica, synthetic clays such as polymer powders including natural, synthetic, and semisynthetic cellulose
  • the personal care composition may comprise from about 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 25%, 20%, 10%, 7%, 5%, or 3% by weight of the composition, of one or more oil control agents.
  • the personal care compositions may comprise a phytosterol.
  • one or more phytosterols can be selected from the group consisting of ⁇ -sitosterol, campesterol, brassicasterol, A5-avennasterol, lupenol, a-spinasterol, stigmasterol, their derivatives, analogs, and combinations thereof.
  • the phytosterol is selected from the group consisting of ⁇ -sitosterol, campesterol, brassicasterol, stigmasterol, their derivatives, and combinations thereof.
  • the phytosterol is stigmasterol.
  • Phytosterols can be synthetic or natural in origin and can be used as essentially pure compounds or mixtures of compounds (e.g. , extracts from natural sources).
  • phytosterols are generally found in the unsaponifiable portion of vegetable oils and fats and are available as free sterols, acetylated derivatives, sterol esters, ethoxylated or glycosidic derivatives. More preferably, the phytosterols are free sterols.
  • phytosterol includes isomers and tautomers of such and is commercially available from Aldrich Chemical Company, Sigma Chemical Company, and Cognis.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more phytosterol.
  • compositions may include hexamidine compounds, its salts, and derivatives.
  • hexamidine compound means a compound having the formula:
  • R 1 and R 2 are optional or are organic acids (e.g. , sulfonic acids, etc.).
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 25%, 20%, 10%, 7%, 5%,or 3%, by weight of the composition, of one or more hexamine compounds.
  • hexamidine derivatives include any isomers and tautomers of hexamidine compounds including but not limited to organic acids and mineral acids, for example sulfonic acid, carboxylic acid, etc.
  • the hexamidine compounds include hexamidine diisethionate, commercially available as Eleastab ⁇ HP 100 from Laboratoires Serobi unanimouss.
  • the personal care composition may comprise a tightening agent.
  • a tightening agent is a compound capable of having a tightening effect on keratinous tissues and, typically, on skin.
  • Suitable tightening agents may be chosen from plant or animal proteins and their hydrolysates such as maize, rye, wheat, buckwheat, sesame, spelt, pea, bean, lentil, soybean and lupin; polysaccharides of natural origin including (i) polyholosides, for example, in the form of starch derived especially from rice, maize, potato, cassava, peas, wheat, oats, etc.
  • carrageenans alginates, agars, gellans, cellulose polymers and pectins, advantageously as an aqueous dispersion of gel microparticles, and (ii) latices composed of shellac resin, gum sandarac, dammars, elemis, copals, cellulose compounds, and mixtures thereof; mixed silicates including phyllosilicaies and in particular laponites; colloidal particles of inorganic fillers such as silica/alumina colloidal particles such as those sold under then tradename LUDOX® by W.R.
  • the personal care composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3% by weight of the composition, of one or more tightening agent.
  • compositions of the present invention can comprise a one or more anti-wrinkle actives or anti-atrophy actives.
  • exemplary anti-wrinkle/anti-atrophy actives suitable for use in the compositions of the present invention include dialkanoyl hydroxyproline compounds, hydroxy acids ⁇ e.g. , glycolic acid, lactic acid, lactobionic acid), keto acids (e.g. , pyruvic acid), phytic acid, lysophosphatidic acid, stilbenes, cinnamates, resveratrol, kinetin, zeatin, dimethylaminoethanol, peptides from natural sources (e.g. , soy peptides), and salts of sugar acids (e.g.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 30%, 25%,20%, 10%, 7%, 5%, or 3% by weight of the composition, of one or more anti-wrinkle/anti-atrophy compounds.
  • Suitable dialkanoyl hydroxyproline compounds of the present invention can include those corresponding to the following chemical formula:
  • R 1 is H, X, C1-C20 straight or branched alkyl, X is metals (Na, K, Li, Mg, Ca) or amines (DEA, TEA);
  • R 2 is C1-C20 straight or branched alkyl
  • R 3 is Ci-C2 0 straight or branched alkyl.
  • Suitable derivatives include but are not limited to esters, for example fatty esters, including, but not limited to tripalmitoyl hydroxyproline and dipalmityl acetyl hydroxyproline.
  • a particularly useful compound is dipalmitoyl hydroxyproline.
  • dipalmitoyl hydroxyproline includes any isomers and tautomers of such and is commercially available under the tradename Sepilift ⁇ ® from Seppic, inc. Further discussion of dipalmitoyl hydroxyproline appears in PCT Publication WO 93/23028.
  • the dipalmitoyl hydroxyproline is the triethanolamine salt of dipalmitoyl hydroxyproline as discussed in U.S. Patent No. 7,285,570.
  • compositions of the present invention can comprise a flavonoid compound.
  • Flavonoids are broadly disclosed in U.S. Patents 5,686,082 and 5,686,367.
  • Examples of flavonoids particularly suitable for use in the present invention are one or more flavones, one or more isollavones, one or more coumarins, one or more chromones, one or more dicoumarols, one or more chromanones, one or more chromanols, isomers (e.g. , cis/trans isomers) thereof, and mixtures thereof.
  • Exemplary flavonoids include flavones and isoflavones, in particular daidzein (7,4'- dihydroxy isoflavone), genistein (5,7,4'-trihydroxy isoflavone), equol (7,4'-dihydroxy isoflavan), 5,7-dihydroxy-4'-methoxy isoflavone, soy isollavones (a mixture extracted from soy) and other plant sources of such mixtures (e.g. , red clover), and mixtures thereof.
  • Other exemplary materials inlcude flavanones such as hesperitin, hesperidin, and mixtures thereof.
  • Flavonoid compounds useful herein are commercially available from a number of sources, e.g., Indofine Chemical Company, Inc., Steraloids, Inc., and Aldrich Chemical Company, Inc.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01%, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more flavonoid compounds.
  • the topical compositions of the present invention can comprise one or more N-acyl amino acid compounds.
  • the amino acid can be one of any of the amino acids known in the art.
  • the N-acyl amino acid compounds of the present invention can correspond to the formula: O H
  • R can be a hydrogen, alkyl (substituted or unsubstituted, branched or straight chain), or a combination of alkyl and aromatic groups.
  • R 1 can be C i to C30 , saturated or unsaturated, straight or branched, substituted or unsubstituted alkyls; substituted or unsubstituted aromatic groups; or mixtures thereof.
  • the N-acyl amino acid compound may be selected from the group consisting of N-acyl Phenylalanine, N-acyl Tyrosine, their isomers, their salts, and derivatives thereof.
  • the amino acid can be the D or L isomer or a mixture thereof.
  • N-acyl Phenylalanine corresponds to the following formula:
  • R 1 can be Ci to C30 , saturated or unsaturated, straight or branched, substituted or unsubstituted alkyls; substituted or unsubstituted aromatic groups; or mixtures thereof.
  • N-acyl Tyrosine corresponds to the following formula:
  • R 1 can be C ⁇ to C30 , saturated or unsaturated, straight or branched, substituted or unsubstituted alkyls; substituted or unsubstiluted aromatic groups; or mixtures thereof.
  • N-undecylenoyl-L-phenylalanine Particularly useful as a topical skin tone evening cosmetic agent is N-undecylenoyl-L- phenylalanine.
  • This agent belongs to the broad class of N-acyl Phenylalanine derivatives, with its acyl group being a C I 1 mono-unsaturated fatty acid moiety and the amino acid being the L- isomer of phenylalanine.
  • N-undecylenoyl-L-phenylalanine corresponds to the following formula:
  • N-iindecylenoyl-L-phenylalanine is commercially available under the tradename Sepiwhite ⁇ from SEPP1C.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more N-acyl amino acids.
  • the personal care compositions may comprise one or more retinoid.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more retinoids.
  • concentration used in a composition will depend on the specific retinoid selected since their potency can vary considerably.
  • retinoid includes all natural and/or synthetic analogs of Vitamin A or retinol-like compounds which possess the biological activity of Vitamin A in the skin as well as the geometric isomers and stereoisomers of these compounds.
  • the retinoid may be selected from retinol, retinol esters (e.g. , C2 - C22 alkyl esters of retinol, including retinyl palmitate, retinyl acetate, retinyl propionate), retinal, and/or retinoic acid (including all-trans retinoic acid and/or 13-cis-retinoic acid), or mixtures thereof.
  • retinoids which are described in U.S. Patent Nos.
  • Suitable retinoids may include tocopheryl-retinoate [tocopherol ester of retinoic acid (trans- or cis-), adapalene (6- [3-( l -adamantyl)-4-methoxyphenyl]-2-naphthoic acid ) , and tazarotene (ethyl 6-[2-(4,4- dimethylthiochroman-6-yl)-ethynyl]nicotinate).
  • tocopheryl-retinoate tocopherol ester of retinoic acid (trans- or cis-)
  • adapalene 6- [3-( l -adamantyl)-4-methoxyphenyl]-2-naphthoic acid )
  • tazarotene ethyl 6-[2-(4,4- dimethylthiochroman-6-yl)-ethynyl]nicotinate
  • Suitable retinoids include retinol, retinyl palmitate, retinyl acetate, retinyl propionate, retinal and combinations thereof.
  • retinyl propionate may be used in amounts from about 0. 1 % to about 0.3%.
  • the personal care composition may comprise a peptide.
  • Suitable peptides can include, but are not limited to, di-, tri-, tetra-, penta-, and hexa-peptides and derivatives thereof.
  • the compositions comprise from about l x l 0 ⁇ 7 % to about 20%, from about 1 x 10 " °% to about 10%, or from about lx l 0 "5 % to about 5%, by weight of a peptide.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 25%, 20%, 10%, 7%, 5%, 3%, by weight of the composition, of one or more peptides.
  • peptide refers to pept ides containing ten or fewer amino acids and their derivatives, isomers, and complexes with other species such as metal ions (e.g. , copper, zinc, manganese, magnesium, and the like).
  • Peptide refers to both naturally occurring and synthesized peptides. Also useful herein are naturally occurring and commercially available compositions that contain peptides.
  • the peptides may contain at least one basic amino acid (e.g. , histidine, lysine, arginine).
  • suitable peptides are the dipeptide carnosine (beta-ala-his), the tripeptide gly-his-lys, the tripeptide his-gly-gly, the tripeptide gly-gly-his, the tripeptide gly-his- gly, the tetrapeptide gly-gln-pro-arg, the pentapeptide lys-thr-thr-lys-ser, lipophilic derivatives of peptides, and metal complexes of the aforementioned (e.g. , copper complex of the tripeptide his- gly-gly (also known as Iamin)).
  • dipeptide carnosine beta-ala-his
  • the tripeptide gly-his-lys the tripeptide his-gly-gly
  • the tripeptide gly-gly-his-his the tripeptide gly-his- gly
  • Suitable peptides include Peptide C (arg-lys-arg); Peptide CK+ (ac-arg-lys-arg-NH2); and Peptide E, arg-ser-arg-lys.
  • a commercially available tripeptide derivative-containing composition is Biopeptide CL® (from Sederma, France), which contains 100 ppm of palmitoyl-gly-his-lys and is commercially available.
  • a commercially available pentapeptide derivative-containing composition is atrixyl (from Sederma, France), which contains 100 ppm of palmitoyl-lys-thr-thr-lys-ser.
  • a suitable peptide is a dipeptide based molecule having a C terminal amino acid of threonine, such as plamitoyl-lys-thr, as described in US Patent Application Publication 2007/0020220 A 1 .
  • Peptide derivatives useful herein include lipophilic derivatives such as palmitoyl derivatives.
  • the peptide is selected from palmitoyl-lys-thr-thr-lys-ser, palmitoyl-gly-his-lys, their derivatives, and combinations thereof.
  • compositions of the present invention can comprise one or more particulate materials.
  • particulate materials useful in the present invention include colored and uncolored pigments, interference pigments, inorganic powders, organic powders, composite powders, optical brightener particles, and combinations thereof. These particulates can, for instance, be platelet shaped, spherical, elongated or needle-shaped, or irregularly shaped, surface coated or uncoated, porous or non-porous, charged or uncharged, and can be added to the current compositions as a powder of as a pre-dispersion.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, 1 %, or 2% to about 50%, 25%, 20%, 10%, 7%, 5%, or 3% by weight of the composition, of particulate(s).
  • the pigment, colorant or filler powders used in the composition.
  • Particulate materials useful herein can include, but are not limited to, bismuth oxychloride, sericite, mica, mica treated with barium sulfate or other materials, zeolite, kaolin, silica, boron nitride, lauroyl lysine, nylon, polyethylene, talc, styrene, polypropylene, polystyrene, ethylene/acrylic acid copolymer, polyurethane, aluminum oxide, silicone resin, barium sulfate, calcium carbonate, cellulose acetate, PTFE, polymethyl methacrylate, starch, modified starches such as aluminum starch octenyl succinate, silk, glass, and mixtures thereof.
  • particulates include, but are not limited, to polymeric particles chosen from the polymethylsilsesquioxane resin microspheres such as including materials sold under the tradename Tospearl ® by Momentive Performance Materials Inc., microspheres of polymethylmethacrylates such Micropearl M305 by SEPPIC, spherical particles of crosslinked polydimethylsiloxanes, especially such as those sold by Dow Corning 9506 Cosmetic Power by Dow Corning, spherical particles of polyamide and more specifically Nylon 12 such as Orgasol ® 2002 line by Atochem, polystyrene microspheres such as for example those sold under the name Dynospheres® by Dyno Particles, ethylene acrylate copolymer sold under the name EA209 by Kobo, .PTFE, polypropylene, aluminum starch ocetenylsuccinate such as those sold under the name Dry-Flo® by AkzoNobel, microspheres of polyethylene such as those sold under the
  • Interference pigments are defined as thin platelike layered particles having two or more layers of controlled thickness with different refractive indices that yield a characteristic reflected color from the interference of typically two, but occasionally more, light reflections, from different layers of the platelike particle.
  • the most common examples of interference pigments are micas layered with about 50 - 300 nm films of Ti02, Fe203, silica, tin oxide, and/or Cr203. Such pigments are often pearlescent. Pearl pigments reflect, refract and transmit light because of the transparency of pigment particles and the large difference in the refractive index of mica platelets and, for example, the titanium dioxide coating.
  • interference pigments are available commercially from a wide variety of suppliers, for example, Rona (TimironTM and DichronaTM ), Presperse (FlonacTM ), Englehard (Duochrome 1 M ), Kobo (KTZ Interfine and KTZ Interval), BASF (ReflecksTM) and Eckart (Prestige series).
  • Suitable interference pigments may have a small particle sizes, with an average diameter of individual particles less than about 75 microns in the longest direction, or less than about 50 microns.
  • Suitable particulate materials include pigments which can provide color to the personal care composition.
  • Suitable pigments include inorganic pigments, organic pigments and combinations thereof.
  • useful inorganic pigments include iron oxides, ferric ammonium ferrocyanide, manganese violet, ultramarine blue, and Chrome oxide.
  • Organic pigments can include natural colorants and synthetic monomeric and polymeric colorants. An example is phthalocyanine blue and green pigment.
  • Also useful are encapsulated soluble or insoluble dyes and other colorants.
  • Inorganic white or uncolored pigments useful in the present invention for example Ti02, ZnO, or Zr02, are commercially available from a number of sources.
  • a suitable particulate material contains the material available from U.S. Cosmetics (TRONOX Ti02 series, SAT-T CR837, a rutile Ti02).
  • pigments include charged dispersions of titanium dioxide, as are disclosed in U.S. Patent No. 5,997,887.
  • Colored or uncolored pigments may have a primary average particle size of from about 10 nm, 15 nm, or 20 nm to about 100,000 nm, 5,000nm, or l OOOnm. Mixtures of the same or different pigments having different particle sizes are also useful herein (e.g. , incorporating a T1O2 having a primary particle size of from about 100 nm to about 400 nm with a T1O2 having a primary particle size of from about 10 nm to about 50 nm). ⁇
  • the particulate materials can be surface treated to provide added stability and/or for ease of formulation.
  • suitable coating materials include silicones, lecithin, amino acids, metal soaps, polyethylene and collagen. These surface treatments may be hydrophobic or hydrophilic. Particularly useful hydrophobic pigment treatments include polysiloxane treatments such as those disclosed in U.S. Patent 5, 143,722.
  • UV Actives The compositions of the subject invention may optionally contain a UV active.
  • UV active includes both sunscreen agents and physical sunblocks. Suitable U V actives may be organic or inorganic. Suitable UV actives are listed in the functional category of "Sunscreen Agents" in the Personal Care Product Council's International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition, 2010.
  • UV actives include 2- ethylhexyl-p-methoxycinnamate (commercially available as PARSOL ® CX from DSM), 2- hydroxy-4-mefhoxybenzophenone, benzonphenone-3 (i.e. oxybeznone), octyldimethyl-p- aminobenzoic acid, digalloyltrioleate, .
  • UV actives useful in the compositions of the present invention are 2- ethylhexyl-p-methoxycinnamate, 4-tert-butyl-4'-methoxy dibenzoylmethane, 2-hydroxy-4- methoxybenzo-phenone, 2-phenylbenzimidazole-5-sulfonic acid, octocrylene, zinc oxide, titanium dioxide, and mixtures thereof.
  • UV actives include 4-methylbenzylidene camphor (commercially available as PARSOL® 5000 from DSM or Eusolex 6300 from Merck), methylene bis-benzotriazolyl tetramcthylbulylphenol (i.e. , bisoctrizole, commercially available as Tinosorb ® M from BASF), bis-ethylhexyloxyphenol methoxyphenol triazine (i.e.
  • bemotrizinol commercially available as Tinosorb ® S from BASF
  • disodium phenyl dibenzimidazole tetrasulfonate i.e., Bisdisulizole disodium, commercially available as Neo Heliopan ® AP from Symrise
  • Ethylhexyl triazone commercially available as Uvinul® T 150 from BASF
  • Drometrizole trisiloxane marketed as Mexoryl XL by L'Oreal
  • Sodium Dihydroxy Dimethoxy Disulfobenzophenone i.e.
  • benzophenone-9 commercially available as Uvinul ® DS 49 from BASF
  • Diethylamino Hydroxybenzoyl Hexyl Benzoate commercially available as Uvinul A Plus from BASF
  • diethylhexyl butamido triazone i.e. , Iscotrizinol, commercially available as Uvasorb ® HEB by 3V Sigma
  • Polysilicone- 15 i.e. , commercially available as PARSOL® SLX from DSM
  • Isoamyl p-Methoxycinnamate i.e. , amiloxate, commercially available as Neo Heliopan E 1000 from Symrise
  • alpha-cyanodiphenylacrylate is as disclosed in U.S. Patent No. 7,713,519.
  • the alpha-cyanodiphenylacrylate may have the general formula:
  • R l and R2 is independently a straight or branched chain Cl-30 alkoxy radical and any non-alkoxy R l or R2 radical is hydrogen; and R3 is a straight or branched chain Cl -30 alkyl.
  • R l and R2 is independently a C l -8 alkoxy radical and any non-alkoxy R l or R2 radical is hydrogen; and R3 is a straight of branched chain C2-20 alkyl.
  • R l and R2 is independently methoxy, and any non-methoxy R l or R2 is hydrogen; and R3 is a straight or branched chain C2-20 alkyl.
  • a suitable alpha-cyanodiphenylacrylate is ethylhexyl methoxycrylene, or 2-ethylhexyl 2- cyano-3-(4-methoxyphenyl)-3-phenylpropenoate, wherein R l is methoxy, R2 is hydrogen, and R3 is 2-ethylhexyl.
  • This material is available from Hallstar Company under trade name Solastay ® S 1 .
  • Another suitable photostabilizer includes diesters or polyesters of naphthalene dicarboxylic acid as disclosed in U.S. Patent Nos. 5,993,789, 6, 1 13,931 , 6, 126,925 and 6,284,916.
  • Suitable diesters or polyesters of naphthalene dicarboxylic acid may have the following formula:
  • each R independently is an alkyl group having 1 to 22 carbon atoms, or a diol having the formula HO-R 2 -OH, or a polyglycol having the formula l-IO-R 3 -(-0-R 2 -) m -OH, and, wherein R 2 and R 3 , same or different, are each an alkylcne group, straight chain or branched, having 1 to
  • naphthalene dicarboxylic acid is diethylhexyl 2,6-naphthaIate available as Corapan ® TQ from Symrise.
  • Another suitable photostabilizer is 4-hydroxybenzylidenemalonate derivatives or 4- hydroxycinnamate derivatives.
  • Suitable materials ma have the following formula:
  • R' is hydrogen, a linear or branched C ⁇ -C & alkyl radical or a linear or branched d-Cs alkoxy radical; and
  • R" is a linear or branched Cj-Cg alkyl radical.
  • Exemplary compounds include ethyl-alpha- cyano-3,5-dimelhoxy-4-hydroxy cinnamatc, ethyl-alpha-acetyl-3,5-dimethoxy-4-hydroxy cinnamate, iso-propyl-alpha-acctyl-3,5-dimcthoxy-4-hydroxy cinnamatc, iso-amyl-alpha-acetyl- 3,5-dimethoxy-4-hydiOxy cinnamate, 2-ethylhexyl-alpha-acetyl-3,5-dimethoxy-4-hydroxy cinnamate, diethyl-3,5-dimethoxy-4-hydroxy benzylidene malonate, di-(2-ethylhexyl)-3,5- dimethoxy-4-hydroxy benzylidene malonate, diisoamyl-3,5-dimethoxy-4-hydroxy benzylidene malonate,
  • Suitable photostabilizer is a 2-pyrrolidinone-4-carboxy ester compounds.
  • Suitable 2-pyrrolidinone-4-carboxy ester compounds may have the following formula:
  • R 1 is a linear or branched C1-C20 alkyl radical
  • R 2 is a linear or branched C1-C20 alkyl radical which can contain a C5-C6 ring, the phenyl radical, the benzyl radical or the phenethyl radical.
  • Exemplary radicals for R 1 and R 2 include methyl, ethyl, n-propyl, isopropyl, n- butyl, isobiityl, tcrt-butyl, n-oclyl, 2-ethylhexyl, dodecyl, hexadecyl, cyclohexyl and methylcyclohexyl radicals.
  • 2-pyrrolidinone-4-carboxy ester compounds are provided in U.S. Patent Application Publication No. 2010/0183529.
  • Suitable pholostabilizers include:
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, or 5%, by weight of the composition, of one or more suitable photostabilizer.
  • the personal care composition may comprise at least one photostabilzer and at least one UV active.
  • the U V active is a clibenzoylmethane derivative.
  • the UV active is 4,4'-t-butyl methoxydibenzoyl-melhane (i.e., avobenzone).
  • compositions of the present invention may also comprise an anti-cellulite agent.
  • Suitable agents may include, but are not limited to, xanthine compounds (e.g. , caffeine, theophylline, theobromine, aminophylline, chloroethyltheophylline, dyphylline, etamiphylline, proxyphylline, and the like); extracts of tea, coffee, guarana, mate, cola (Cola nitida); extracts of climbing ivy (Hedera helix), arnica (Arnica montana L), rosemary (Rosmarinus officinalis N), of marigold (Calendula officinalis), sage (Salvia officinalis L), ginseng (Panax ginseng), St.
  • xanthine compounds e.g. , caffeine, theophylline, theobromine, aminophylline, chloroethyltheophylline, dy
  • John's wort Hypericum perforatum
  • butcher's broom Ruscus aculeatus L
  • meadowsweet Filipendula ulmaria L
  • orthosiphon Orthosiphon stamincus benth
  • birch Bommea alba
  • cecropia and argan tree Ginkgo biloba, horsetail, escin, cangzhu, Chrysanthellum indicuin, Dioscorea plants rich in diosgenin or pure diosgenin or hecogenin and compounds thereof, Ballota, Guioa, Davallia, Terminalia, Barringtonia, Trema, Antirobia, bitter orange (Citrus aurantiuin); and an extract of cocoa bean shells (Theobroma cacao) such as sold under the name Caobromine ® by Solabia.
  • the personal care composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more anti-cellu lite agents.
  • a desquamation active may be added to the compositions of the present invention.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more desquamation actives.
  • Suitable desquamation actives include beta-hydroxy acids such as salicylic acid and its derivatives (including 5-(noctanoyl)salicylic acid also known as capryloyl salicylic acid) and alpha-hydroxy acids such as glycolic acid, citric acid, lactic acid, tartaric acid, malic acid or mandelic acid; 8-hexadecene-l,16-dicarboxylic acid or 9-octadecenedioic acid; urea; gentisic acid; oligofucoses; cinnamic acid; Saphora Japonica extract; and resveratrol.
  • beta-hydroxy acids such as salicylic acid and its derivatives (including 5-(noctanoyl)salicylic acid also known as capryloyl salicylic acid) and alpha-hydroxy acids such as glycolic acid, citric acid, lactic acid, tartaric acid, malic acid or mandelic acid; 8-hexadecene-l,16-
  • Suitable desquamation actives include compounds acting on the enzymes involved in desquamating or degrading the corneodesmosomes, glycosidases, stratum corneum chymotryptic enzyme (SCCE) or other proteases (trypsin, chymotrypsin-like).
  • Suitable materials include aminosulphonic compounds such as 4-(2-hydroxyethyl)piperazine-l-propanesulphonic acid (HEPES); 2-oxothiazolidine-4-carboxylic acid (procysteine) and its compounds; compounds of glycine-type alpha-amino acids (as described in U.S. Patent Application Publication No.
  • One desquamation system comprises salicylic acid and zwitterionic surfactants as described in U.S. Patent No. 5,652,228.
  • Another desquamation system contains sulfhydryl compounds and zwitterionic surfactants as described in U.S. Patent No. 5,681 ,852
  • compositions of the present invention can comprise one or more anti-acne actives.
  • Suitable anti-acne actives include, but are not limited to, resorcinol, sulfur, salicylic acid, retinoids such as retinoic acid and its derivatives, sulfur-containing amino acids and their derivatives and salts (e.g. , N-acetyl derivatives such as N-acetyl-L-cysteinc), and lipoic acid.
  • suitable anti-acne actives may be chosen from (i) antibiotics and antimicrobials such as benzoyl peroxide, octopirox, tetracycline, 2,4,4'trichloro-2'-hydiOxy diphenyl ether, 3,4,4'- trichlorobanilide, azelaic acid and its derivatives, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, ethyl acetate, clindamycin and meclocycline; (ii) sebostats such as flavonoids; and (iii) bile salts such as scymnol sulfate and its derivatives, deoxycholate, and cholate. Further examples of suitable anti-acne actives are described in U. S. Patent No. 5,607,980.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more anti-acne compounds.
  • compositions of the present invention can include an anti-oxidant/radical scavenger.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more anti-oxidant/radical scavengers.
  • Suitable anti-oxidants are listed in the functional category of "Antioxidants” in the Personal Care Product Council's International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition, 2010.
  • Suitable anti-oxidants include butylatecl hydroxytoluene (BUT) and butylated hydroxyanisole (BHA).
  • BUT butylatecl hydroxytoluene
  • BHA butylated hydroxyanisole
  • X is OH or SH
  • Y is selected from the group consisting of H, OH, OR 5) COOR5, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aromatic, heteroaromatic, carboxamido, sulfonamido, carbamate, urea, and trialkylsilyl;
  • Ri , R 2, R3, 4 are selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aromatic, heteroaromatic, OR5, carboxamido, sulfonamido, formyl, acyl, carboxyl, carboxylate, carbamate, urea, trialkylsilyl, hydroxyl, and hydrogen;
  • anti-oxidants/radical scavengers such as ascorbic acid (vitamin C), tocopherol (vitamin E), tocopherol sorbate, tocopherol acetate, other esters of tocopherol, 6-hydroxy-2,5,7,8- tetramethylchroman-2-carboxylic acid (commercially available under the tradename Trolox ⁇ ), amines (e.g.
  • Suitable anti-oxidants/radical scavengers can be selected from esters of tocopherol such as tocopherol acetate.
  • the composition comprises tocopherol sorbate.
  • tocopherol sorbate refers to the sorbic acid ester of tocopherol, a detailed description of which can be found in issued patent US 5,922,758.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05 %, 0. 1 %, 0.5%, or 1 % to about 50%, 25%, 20%, 10%, 7%, or 5%, by weight of the composition, of the tocopherol sorbate.
  • compositions of the present invention can contain a safe and effective amount of a conditioning agent selected from, for example, humectants, moisturizers, occlusives, and emollients which may be applied to keratinous tissue.
  • a conditioning agent selected from, for example, humectants, moisturizers, occlusives, and emollients which may be applied to keratinous tissue.
  • the composition may comprise from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1%, 0.5%, or 1 % to about 50%, 25%, 20%, 10%, 7%, or 5%, by weight of the composition, of one or more conditioning agents.
  • Humectants are one group of conditioning agents.
  • Humectants can be selected from the group consisting of polyhydric alcohols, water soluble alkoxylated nonionic polymers, and mixtures thereof.
  • Polyhydric alcohols useful herein include glycerin, sorbitol, propylene glycol, butylene glycol, pcntylene glycol, hexylene glycol, ethoxylated glucose, 1 , 2-hexane diol, hexanetriol, dipropylene glycol, erythritol, trehalose, diglycerin, xylitol, maltitol, maltose, glucose, fructose, sodium chondroitin sulfate, sodium hyaluronate, hyaluronic acid, sodium adenosine phosphate, sodium lactate, pyrrolidone carbonate, glucosamine, cyclodextrin, and mixtures thereof.
  • conditioning agents include water soluble alkoxylated nonionic polymers such as polyethylene glycols and polypropylene glycols having a molecular weight of up to about 1000 such as those with CTFA names PEG-200, PEG-400, PEG-600, PEG- 1000, and mixtures thereof.
  • conditioning agents include, but are not limited to, guanidine, urea, glycolic acid, glycolate salts (e.g. ammonium and quaternary alkyl ammonium), salicylic acid, lactic acid, lactate salts (e.g.
  • aloe vera in any of its variety of forms (e.g., aloe vera gel), polyethylene glycols, sugars (e.g., melibiose), cellulose, dextrin, starches, sugar and starch derivatives (e.g., alkoxylated glucose, fucose), lactamide monoethanolamine, acetamide monoethanolamine, panthenol, allantoin, amylose, hyaluronic acid, sodiium hyaluronate, betaglucan, glycogen, alguronic acid, galactoarabinan and mixtures thereof.
  • aloe vera gel e.g., aloe vera gel
  • sugars e.g., melibiose
  • cellulose e.g., dextrin, starches, sugar and starch derivatives (e.g., alkoxylated glucose, fucose), lactamide monoethanolamine, acetamide monoethanolamine, panthenol, allant
  • Conditioning agents are extracts that contain polysaccharides including the following materials: TriMoist MF (Mibelle AG Biochemistry), Fucogel® and Glycofilm® (Solabia Group), AquaxylTM (Seppic), Pheohydrane P (Barnet Products Corporation), Aesthigel (Barnet Products Corporation), Pentacare HP (Pentapharm), and Hyalurosmooth (Laboratoires Serobi GmbH).
  • Steroidal anti-inflammatory agents can include, but are not limited to, corticosteroids such as hydrocortisone.
  • nonsteroidal anti-inilammatory agents can be useful herein.
  • the varieties of compounds encompassed by this group are well known to those skilled in the art.
  • Specific non-steroidal anti-inflammatory agents that can be useful in the composition of the present invention include, but are not limited to, salicylates, flufenamic acid, etofenamate, aspirin, and mixtures thereof.
  • Additional anti-inflammatory agents useful herein include allantoin and compounds of the
  • Licorice the plant genus/species Glycyrrhiza glabra family, including glycyrrhetic acid, glycyrrhizic acid, and derivatives thereof (e.g. , salts and esters).
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 50%, 25%, 20%, 10%, 7%, or 5%, by weight of the composition, of one or more anti-inflammatory agents.
  • compositions of the present invention can comprise a tanning active.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 50%, 25%, 20%, 10%, 7%, or 5%, by weight of the composition, of a tanning active.
  • a suitable tanning active is dihydroxyacetone.
  • compositions of the present invention can comprise a skin lightening agent.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 50%, 25%, 20%, 10%, 7%, or 5%, by weight of the composition, of one or more skin lightening agents.
  • Suitable skin lightening agents include those known in the art, including ascorbyl glucoside, kojic acid, hydroquinone arbutin, and tranexamic acid.
  • Other skin lightening materials suitable for use herein can include Acitwhite® (Cognis), Embiica ® (Rona), Azeloglicina (Sinerga) and extracts (e.g.
  • An exemplary skin lightening agent is ascorbyl glucoside.
  • Other skin lightening actives include Phlorogine and Phlorgine BG (laininaria saccharina extract), deoxyarbutin, sucrose dilaurate, bakuchiol, pyrenoine, millet, arlatone dioic acid, cinnamic acid, ferulic acid, achromaxyl, methyl nicotinamide, oil soluble licorice extract, folic acid, undecylenic acid, zinc undecylenate, L- tryptophan, thiamine HQ, hexylresorcinol, lipidami red vine, dragosine, methyl gentisate, inositol, 1 ,2-hexandiol and 1 ,2-octandiol (available as Symdiol 68 from Symrise), laminaine, their salts, their derivatives, their precursors,
  • the personal care composition may comprise botanical extracts.
  • the composition may comprises from about 0.0001 %, 0.0005% 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, 3%, by weight of the composition, of one or more botanical extracts.
  • Suitable botanical extracts include extracts from plants (herbs, roots, flowers, fruits, seeds) such as flowers, fruits, vegetables, and so on, including yeast ferment extract, Padina Pavonica extract, thermus thermophilis ferment extract, camelina saliva seed oil, boswellia serrata extract, olive extract.bodopsis Thaliana extract, Acacia Dealbata extract, Acer Saccharintim (sugar maple), acidopholus, acorus, aesculus, Alicaligenes polysaccharides, agaricus, agave, agrimonia, algae, aloe, citrus, brassica, cinnamon, orange, apple, blueberry, cranberry, peach, pear, lemon, lime, pea, seaweed, caffeine, green tea, chamomile, willowbark, mulberry, poppy, and the like.
  • yeast ferment extract including yeast ferment extract, Padina Pavonica extract, thermus thermophilis ferment extract, camelina saliva seed oil, boswellia serrata extract, olive
  • Glycyrrhiza Glabra Salix Nigra, Macrocycstis Pyrifera, Pyrus Malus, Saxifraga Sarmentosa, Vitis Vinifera, Morus Nigra, Scutellaria Baicalensis, Anthemis Nobilis, Salvia Sclarea, Rosmarinus Officianalis, Citrus edica Limonum, Ginkgo Biloba Panax Ginseng, Siegesbeckia Orientalis, Fructus Mume, Ascophyllum Nodosum, Bifida Ferment lysate, Glycine Soja extract, Beta Vulgaris, Haberlea Rhodopensis, Polygonum Cuspidatum, Citrus Aurantium Dulcis, Vitis Vini fera, Selaginella Tamariscina, Hum lus Liipulus, Citrus Reticulata Peel, Punica Granatum, Asparagopsis, Curcuma Longa, Menyanthes Trifoliat
  • the personal care compositions can comprise an antimicrobial or antifungal active.
  • a safe and effective amount of an antimicrobial or antifungal active can be added to the present compositions.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more antimicrobial, antibactcrialand/or antifungal actives.
  • Suitable actives useful herein include those selected from the group consisting of benzoyl peroxide, 3-hydroxy benzoic acid, glycolic acid, lactic acid, 4-hydroxy benzoic acid, 2- hydroxybutanoic acid, 2-hydroxypentanoic acid, 2-hydroxyhexanoic acid, phytic acid, lipoic acid, azclaic acid, arachidonic acid, benzoylpcroxide, tetracycline, ibuprofen, naproxen, hydrocortisone, acetominophcn, resorcinol, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, lidocaine hydrochloride, neocycin sulfate, and mixtures thereof.
  • Azole antimicrobials may be used and include imidazoles such as benzimidazole, benzothiazole, bifonazole, butaconazole nitrate, climbazole, clotrimazole, croconazole, eberconazole, econazole, elubiol, fenticonazole, fluconazole, flutimazole, isoconazole, ketoconazole, lanoconazole, metronidazole, miconazole, neticonazole, omoconazole, oxiconazole nitrate, sertaconazole, sulconazole nitrate, tioconazole, thiazole, and triazoles such as terconazole and itraconazole, and combinations thereof.
  • imidazoles such as benzimidazole, benzothiazole, bifonazole, butaconazole nitrate, climbazole, clotrimaz
  • Selenium sul fide may be used as an antimicrobial.
  • Average particle diameters for the selenium sulfide are typically less than 15 ⁇ , as measured by forward laser light scattering device (e.g. , Malvern 3600 instrument), or, alternately, less than 10 ⁇ .
  • Antiperspirant actives may also be included in the compositions of the present invention.
  • Suitable antiperspirant actives include astringent metallic salts, especially the inorganic and organic salts of aluminum zirconium and zinc, as well as mixtures thereof.
  • Exemplary actives include aluminum containing and/or zirconium-containing materials or salts, such as aluminum halides, aluminum chlorohydrate, aluminum hydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides, and mixtures thereof.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 , 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%,, or 3% by weight of the composition, of one or more antiperspirant compounds.
  • the personal care composition may include a warming sensates and/or cooling senate.
  • Sensatcs provide the sensation of heating or cooling to a user, but may or may not yield a change in skin temperature. The sensation may be instantaneous or may be delayed, but, generally, is appreciable within 5 minutes of application of the skin care composition.
  • the composition may comprises from about 0.0001 %, 0.00] %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more sensates. Any mixture of the warming and/or cooling sensates may also be used.
  • warming sensates include ethyl alcohol, niacin, jambu, nicotinic acid, zingerone, vanillyl alcohol n-butyl ether, vanillyl alcohol n-propyl ether, vanillyl alcohol isopropyl ether, vanillyl alcohol isobutyl ether, vanillyl alcohol n-amino ether, vanillyl alcohol isoamyl ether, vanillyl alcohol n-hexyl ether, vanillyl alcohol methyl ether, vanillyl alcohol ethyl ether, gingerol, methyl salicylate, shogaol paradol, zingerone, capsaicin, dihydrocapsaicin, nordihydrocapsaicin, homocapsaicin, homodihydrocapsaicin, ethanol, tincture capsicum, oleoresin ginger alcohol extraction, eucalyptus oil, capsaicin,
  • warming sensatcs include fluid extracts, hydro-alcohol extracts, essential oils, oleoresins, concretes or distillates of mustard seed, ginger, horseradish, chillies, jalapeno, pepper, capsicum, clove, cassia, and mixtures thereof.
  • Suitable cooling sensates include menthol, isopulegole, 3-( l -menthoxy)propan- l ,2-diol, p-menlhan-3,8-diol, 6-isopropyl-9-methyl- 1 ,4-dioxaspiro-(4,5)-decane-2-methanol, menthyl succinate, alkaline earth salts of menthyl succinate, trimethyl cyclohexanol, N-ethyl-2-isopropyl- 5-methylcyclohexane carboxamidc and other carboxamides as described in U.S. Patent No.
  • menthyl lactate 2-(5'-methyl-2 -(methylethyl)cyclohexyloxy)ethan- l-ol, 3-(5'-methyl-2'-(methylethyl)cyclohexyloxy)propan- l -ol, 4-(5'-methyl-2'-(methylethyl) cyclohexyloxy) butan- l -ol, and spearmint.
  • cooling sensatcs include p-menth-3-yl n-butyl sulphoxidc, n-butyl 1 -isobutylcyclohexyl sulphoxide, n-hexyl 1 -isobiitylcyclohexyl sulphoxide, n-butyl 1 -isoamylcyclohexyl sulphoxide and n-hexyl 1 ,2-diethylcyclohexyl sulphoxide, and other cyclic sulphoxides and sulphones as described in U.S. Patent No. 4,032,661.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1 %, 0.5%, or 1 % to about 10%, 7%, 5%, 2%, or 1 %, by weight of the composition, of one or more preservatives.
  • preservatives are suitable, including such as benzoic acid, benzyl alcohol, benzylhemiformal, benzylparaben, 5-bromo-5- nitro- 1 ,3- dioxane, 2-bromo-2-nitropropane- 1 ,3-diol, butyl parabcn, phenoxyethanol, methyl paraben, propyl paraben, diazolidinyl urea, sodium bcnzoate, calcium benzoate, calcium propionate, caprylyl glycol, biguanide derivatives, phenoxyethanol, captan, chlorhexidine diacetate, chlorhexidine digluconate, chlorhexidine dihydrochloride, chloroacetamide, chlorobutanol, p- chloro-m- cresol, chlorophene, chlorothymol, chloroxylenol, m-cresol, o-cresol, DEDM hydantoin, DEDM hydanto, DE
  • the personal care compositions of the present invention may also contain an anti- dandruff agent.
  • the personal care composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0.1 %, 0.5%, or 1 % to about 20%, 10%, 7%, 5%, 4%, 3%, or 2%, by weight of the composition, of one or more anti-dandruff actives.
  • anti-dandruff particulates include: pyridinethione salts, azoles, selenium sulfide, particulate sulfur, and mixtures thereof.
  • pyridinethione anti-dandruff particulates especially l -hydroxy-2-pyridinethione salts
  • Suitable pyridinethione salts include those formed from heavy metals such as zinc, tin, cadmium, magnesium, aluminum and zirconium.
  • zinc or a zinc salt of l -hydroxy-2-pyridinethione (known as "zinc pyridinethione" or "ZPT") may be used
  • l -hydroxy-2-pyridinethione salts may be in platelet particle form, wherein the particles have an average size of up to about 20 ⁇ , up to about 5 ⁇ , or up to about 2.5 ⁇ . Salts formed from other cations, such as sodium, may also be suitable.
  • Pyridinethione anti-dandruff agents are described, for example, in U.S. Pat. Nos. 2,809,971 ; 3,236,733; 3,753, 196; 3,761 ,418; 4,345,080; 4,323,683; 4,379,753; and 4,470,982. It is contemplated that when ZPT is used as the anti-dandruff particulate in the compositions herein, that the growth or re-growth of hair may be sti mulated or regulated, or both, or that hair loss may be reduced or inhibited, or that hair may appear thicker or fuller.
  • the personal care composition can comprise one or more substantivity polymers. These polymers may be used to enhance the deposition and longevity of other ingredients onto the keratinous tissue. These polymers may also improve rub-off resistance and water repellence.
  • the composition may comprises from about 0.0001 %, 0.001 %, 0.01 %, 0.05%, 0. 1%, 0.5%, or 1 % to about 30%, 25%, 20%, 10%, 7%, 5%, or 3%, by weight of the composition, of one or more substantivity polymer.
  • Suitable cationic polymers for use in the compositions of the present invention contain cationic nitrogen-containing moieties such as quaternary ammonium or cationic protonated amino moieties.
  • the cationic protonated amines can be primary, secondary, or tertiary amines (preferably secondary or tertiary), depending upon the particular species and the selected pH of the composition.
  • Any anionic counterions can be used in association with the cationic polymers so long as the polymers remain soluble in water, in the composition, or in a coacervate phase of the composition, and so long as the counterions are physically and chemically compatible with the essential components of the composition or do not otherwise unduly impair product performance, stability or aesthetics.
  • Non limiting examples of such counterions include halides (e.g. , chloride, fluoride, bromide, iodide), sulfate and methylsiil ate.
  • Non limiting examples of suitable cationic polymers include copolymers of vinyl monomers having cationic protonated amine or quaternary ammonium functionalities with water soluble spacer monomers such as acrylamide, methacrylamide, alkyl and dialkyl acrylamides, alkyl and dialkyl methacrylamides, alkyl acrylate, alkyl methacrylate, vinyl caprolactone or vinyl pyrrolidone.
  • Suitable cationic protonated amino and quaternary ammonium monomers for inclusion in the cationic polymers of the composition herein, include vinyl compounds substituted with dialkylaminoalkyl acrylate, dialkylaminoalkyl methacrylate, monoalkylaminoalkyl acrylate, monoalkylaminoalkyl methacrylate, trialkyl methacryloxyalkyl ammonium salt, trialkyl acryloxyalkyl ammonium salt, diallyl quaternary ammonium salts, and vinyl quaternary ammonium monomers having cyclic cationic nitrogen-containing rings such as pyridinium, imidazolium, and quaternized pyrrolidone, e.g. , alkyl vinyl imidazolium, alkyl vinyl pyridinium, alkyl vinyl pyrrolidone salts.
  • Suitable cationic polymers for use in the compositions include copolymers of 1 - vinyl-2-pyrrolidone and l -vinyl-3-methylimidazolium salt (e.g. , chloride salt) (INCI name: Polyquaternium- 16); copolymers of l -vinyl-2-pyrrolidone and dimethylaminoethyl methacrylate (INCI name: Polyquaternium- 1 1 ); cationic diallyl quaternary ammonium-containing polymers, including, for example, dimethyldiallylammonium chloride homopolymer, copolymers of acrylamide and dimethyldiallylammonium chloride (INCI name: Polyquaternium 6 and Polyquaternium 7, respectively); amphoteric copolymers of acrylic acid including copolymers of acrylic acid and dimethyldiallylammonium chloride (INCI name: Polyquaternium 22), terpolymers of acrylic acid with dimethyldiallylammonium chloride and
  • R 1 is hydrogen, methyl or ethyl ; each of R 2 , R 3 and R 4 are independently hydrogen or a short chain alkyl having from about 1 to about 8 carbon atoms; n is an integer having a value of from about 1 to about 8 ; and X is a counterion.
  • the nitrogen attached to R 2 , R 3 and R 4 may be a protonated amine (primary, secondary or tertiary), but is preferably a quaternary ammonium wherein each of R 2 , R 3 and R 4 are alkyl groups a non limiting example of which is polymethyacrylamidopropyl trimonium chloride, available under the trade name Polycare 133, from Rhone-Poulenc.
  • Other suitable cationic polymers for use in the composition include polysaccharide polymers, such as cationic cellulose derivatives and cationic starch derivatives. Suitable cationic polysaccharide polymers include those which conform to the formula:
  • A is an anhydroglucose residual group, such as a starch or cellulose anhydroglucose residual
  • R is an alkylenc oxyalkylenc, polyoxyalkylene, or hydroxyalkylene group, or combination thereof
  • Rl , R2, and R3 independently are alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl, or alkoxyaryl groups, each group containing up to about 18 carbon atoms
  • X is an anionic counterion as described in hereinbefore.
  • Suitable cationic cellulose polymers are salts of hydroxyethyl cellulose reacted with trimethyl ammonium substituted epoxide, INCI name "Polyquaternium 10" and available from Amerchol Corp. (Edison, N.J., USA) in their Polymer LR, JR, and KG series of polymers.
  • Other suitable types of cationic cellulose includes the polymeric quaternary ammonium salts of hydroxyethyl cellulose reacted wilh lauryl dimethyl ammonium-substituted epoxide, INCI name "Polyquaternium 24.” These materials are available from Amerchol Corp. under the tradename Polymer LM-200.
  • Suitable cationic polymers include cationic guar gum derivatives, such as guar hydroxypropyltrimonium chloride, specific examples of which include the Jaguar series commercially avaialable from Rhone-Poulenc Incorporated and the N-Hance series commercially available from Aqualon Division of Hercules, Inc.
  • Other suitable cationic polymers include quaternary nitrogen-containing cellulose ethers, some examples of which are described in U.S. Pat. No. 3,962, 1 8.
  • Other su itable cationic polymers include copolymers of etherified cellulose, guar and starch, some examples of which are described in U .S. Pat. No. 3,958,581.
  • compositions herein can comprise nonionic polymers.
  • polyalkylene glycols having a molecular weight of more than about 1000 can be used. These can include those having the following general formula:
  • Preferred polyethylene glycol polymers can include PEG-2M (also known as Poiyox WSR® N- 10, which is available from Dow Chemical Co.
  • PEG-5M also known as Poiyox WSR ® N-35 and Polyox WSR* 9 N-80, available from Dow and as PEG-5,000 and Polyethylene Glycol 300,000
  • PEG-7M also known as Polyox WSR® N-750 available from Dow
  • PEG-9M also known as Polyox WSR ® -3333 available from Dow
  • PEG- 14 M also known as Polyox WSR ® N-3000 available from Dow.
  • Suitable commercially available substantivity polymers include: Cosmedia DC
  • Polycrylene has the INCI name Polyester-8 and is available from Hallstar Co; Dow Corning FA 4001 CM Silicone Acrylate and Dow Corning FA 4002 ID Silicone Acrylate (copolymer of polytrimethylsiloxymethacrylate and one or more monomers consisting of acrylic acid, methacrylic acid, or one of their simple esters dissolved in cyclopcnlasiloxane or isododecanc, respecti vely); Ganex P-904 (poly(butylated vinylpyrrolidone)), Ganex V-216 (vinylpyrrolidone and hexadecene copolymer), Ganex V-220 (vinylpyrrolidone and eicosene copolymer), and Ganex WP-660 (vinyl pyrrolidone and 1 - triacontane copolymer), all available from International Specialty Products; Phospholipon 9011 (hydrogenated lecithin) available from Phospholipid GmbH;
  • the personal care composition may include one or more detersi ve surfactants.
  • the personal care composition may be in the form of a leave-on product that may be substantially free of cleansing or detersive surfactants.
  • leave-on compositions may comprise less than 1 % cleansing surfactants, less than 0.5% cleansing surfactants, or 0% cleansing surfactants
  • the detersive surfactant component can be included to provide cleaning performance to the composition.
  • the detersive surfactant component in turn can comprise anionic detersive surfactant, zwitterionic or amphoteric detersive surfactant, or a combination thereof.
  • Such surfacta ts should be physically and chemically compatible with the essential components described herein, or should not otherwise unduly impair product stability, aesthetics or performance.
  • Suitable anionic detersive surfactant components for use in the composition herein include those which are known for use in hair care or other personal care cleansing compositions.
  • the concentration of the anionic surfactant component in the composition can preferably be sufficient to provide the desired cleaning and lather performance, which generally can range from about 1 %, 2.5%, 5%, 7.5%, 10%, 12.5%, or 15% to about 50%, 40%, 30%, 25%, 20%, or 10%, by weight of the composition.
  • Suitable anionic surfactants suitable for use in the compositions are the alkyl and alkyl ether sulfates. These materials have the respective formulae ROSO3M and RO(C2H40) x S03M, wherein R is alkyl or alkenyl of from about 8 to about 18 carbon atoms, x is an integer having a value of from 1 to 10, and M is a cation such as ammonium, alkanolamines, such as triethanolamine, monovalent metals, such as sodium and potassium, and polyvalent metal cations, such as magnesium, and calcium.
  • R alkyl or alkenyl of from about 8 to about 18 carbon atoms
  • x is an integer having a value of from 1 to 10
  • M is a cation such as ammonium, alkanolamines, such as triethanolamine, monovalent metals, such as sodium and potassium, and polyvalent metal cations, such as magnesium, and calcium.
  • R has from about 8 to about 1 8 carbon atoms, from about 10 to about 16 carbon atoms, or from about 12 to about 14 carbon atoms, in both the alkyl and alkyl ether sulfates.
  • the alkyl ether sulfates are typically made as condensation products of ethylene oxide and monohydric alcohols having from about 8 to about 24 carbon atoms.
  • the alcohols can be synthetic or they can be derived from fats, e.g. , coconut oil, palm kernel oil, tallow. Lauryl alcohol and straight chain alcohols derived from coconut oil or palm kernel oil are preferred.
  • Such alcohols are reacted with between about 0 and about 10, from about 2 to about 5, or about 3, molar proportions of ethylene oxide, and the resulting mixture of molecular species having, for example, an average of 3 moles of ethylene oxide per mole of alcohol, is sulfated and neutralized.
  • anionic detersive surfactants are the water-soluble salts of organic, sulfuric acid reaction products conforming to the formula [ R I -SO3-M ] where is a straight or branched chain, saturated, aliphatic hydrocarbon radical having from about 8 to about 24 or from about 10 to about 18 carbon atoms; and M is a cation described hereinbefore.
  • anionic detersive surfactants are the reaction products of fatty acids esteri fied with isethionic acid and neutralized with sodium hydroxide where, for example, the fatty acids are derived from coconut oil or palm kernel oil; sodium or potassium salts of fatty acid amides of methyl tauride in which the fatly acids, for example, are derived from coconut oil or palm kernel oil.
  • Other similar anionic surfactants are described in U.S. Pat. Nos. 2,486,921 , 2,486,922, and 2,396,278.
  • anionic detersive surfactants suitable for use in the compositions are the succinnates, examples of which include disodium N-octadecylsulfosuccinnate; disodium lauryl sulfosuccinale; diammonium lauryl sulfosuccinate; tetrasodium N-( l ,2-dicarboxyethyl)-N- octadecylsul fosuccinnate; diamyl ester of sodium sulfosuccinic acid; dihexyl ester of sodium sulfosuccinic acid; and dioctyl esters of sodium sulfosuccinic acid.
  • Suitable anionic detersive surfactants include olefin sulfonates having about 10 to about 24 carbon atoms.
  • the olefin sulfonates can contain minor amounts of other materials, such as alkene disulfonates depending upon the reaction conditions, proportion of reactants, the nature of the starting olefins and impurities in the olefin stock and side reactions during the sulfonation process.
  • alkene disulfonates depending upon the reaction conditions, proportion of reactants, the nature of the starting olefins and impurities in the olefin stock and side reactions during the sulfonation process.
  • Another class of anionic detersive surfactants suitable for use in the personal care composition is beta-alkyloxy alkane sulfonates. These surfactants conform to the formula
  • R ' is a straight chain alkyl group having from about 6 to about 20 carbon atoms, is a lower alkyl group having from about 1 to about 3 carbon atoms, preferably 1 carbon atom, and M is a water-soluble cation as described hereinbefore.
  • Suitable anionic detersive surfactants for use in the compositions include ammonium lauryl sulfate, ammonium laureth sulfate, triethylamine lauryl sulfate, triethylamine laureth sulfate, triethanolamine lauryl sulfate, triethanolaminc laureth sulfate, monoethanolamine lauryl sulfate, monoethanolamine laureth sulfate, diethanolamine lauryl sulfate, diethanolamine laureth sulfate, lauric monoglyceride sodium sulfate, sodium lauryl sulfate, sodium laureth sulfate, potassium lauryl sulfate, potassium laureth sulfate, sodium lauryl sarcosinate, sodium lauroyl sarcosinate, lauryl sarcosinc, cocoyl sarcosine, ammonium cocoyl sulf
  • Suitable amphoteric or zwitterionic detersive ' surfactants for use in the composition herein include those which are known for use in hair care or other personal care cleansing.
  • Amphoteric detersive surfactants suitable for use in the composition are well known in the art, and include those surfactants broadly described as derivatives of aliphatic secondary and tertiary amines in which the aliphatic radical can be straight or branched chain and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic group such as carboxy, sul fonate, sulfate, phosphate, or phosphonate.
  • Preferred amphoteric detersive surfactant ' s for use in the present invention include cocoamphoacetate, cocoamphodiacetate, lauroamphoacetate, lauroamphodiacetate, and mixtures thereof.
  • suitable zwilterionic or amphoteric surfactants are described in U.S. Pat. Nos. 5, 104,646 and 5, 106,609.
  • Zwilterionic detersive surfactants suitable for use in the composition are well known in the art, and include those surfactants broadly described as derivatives of aliphatic quaternary ammonium, phosphonium, and sulfonium compounds, in which the aliphatic radicals can be straight or branched chain, and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic group such as carboxy, sulfonate, sulfate, phosphate or phosphonate. Zwiltcrionics such as betaines are preferred.
  • Suitable optional surfactants include nonionic and cationic surfactants. Any such surfactant known in the art for use in hair or personal care products may be used, provided that the optional additional surfactant is also chemically and physically compatible with the essential components of the composition, or does not otherwise unduly impair product performance, aesthetics or stability.
  • Non limiting examples of other anionic, zwitterionic, amphoteric or optional additional surfactants suitable for use in the compositions are described in McCutcheon's, Einiilsifiers and Detergents, 2010 Annual Ed., published by M. C. Publishing Co., and U.S . Pat. Nos. 3,929,678, 2,658,072, 2,438,091 , and 2,528,378.
  • any other suitable optional component can also be included in the personal care composition of the present invention, such as those ingredients that are conventionally used in given product types.
  • iodopropyl butylcarbamate antifungal agents, antioxidants, binders, buffering agents, bulking agents, chelating agents, colorants, cosmetic astringents, cosmetic biocides, denaturants, drug astringents, external analgesics, film formers, opacifying agents, pH adjusters, plant derivatives, plant extracts, plant tissue extracts, plant seed extracts, plant oils, botanicals, botanical extracts, preservatives, propellants, reducing agents, sebum control agents, sequestrants, skin bleaching agents, skin- conditioning agents ⁇ e.g. humectants and occlusive agents), and skin protectants.
  • Other suitable optional person care ingredients include materials listed in paragraphs 5 13-839 of U.S Patent Application No. 2010/01 12100.
  • Glycerin 10.0 10.0 1 1 1 1 10 10.0 2.0 10.0 2.0
  • exemplary di-amido gellants include dibenzyl (2S,2'S)- 1 , 1 '-(propane- 1 ,3- diylbis(azanediyl))bis(3-mcthyl- 1 -oxobutane-2, 1 -diyl)dicarbamate; dibenzyl (2S,2'S)- 1 , 1 '-(propane- 1 ,3- diylbis(iizanediyl))bis(l -oxo-3-phenylpropane-2, 1 -diyl)dicarbamate; dibenzyl (2S,2'S)- 1 , 1 '-(hexane- 1 ,6- diylbis(azanediyl))bis(l -oxo-3-phcnylpropane-2, l -diyl)dicarbamate; and N, N'-(2S)- 1 , 1 '-
  • Phase A combine the ingredients of Phase A in a suitable container.
  • a suitable container combine the ingredients of Phase B. Heat each phase to 75-80°C while mixing each phase using a suitable mixer (e.g.. Anchor blade, propeller blade) until each reaches temperature and is homogenous. Slowly add Phase B to Phase A while continuing to mix Phase A. Continue mixing unti l batch is uniform. Homogenize product with Ultra-Turrax homogenizer (IKA, Inc) or equivalent and pour product into suitable containers at 75-80°C. Store the containers at room temperature without disturbing for at least 12 hours.
  • a suitable mixer e.g. Anchor blade, propeller blade
  • the ingredients are combined and mixed (with heat if needed) until uni form; the composition may be warmed to dissolve all ingredients. Once the composition is uniform, the product is poured into suitable containers.
  • the di-amido gellant may be added via a premix containing the designed amount of di-amido gellant and suitable amount of carrier fluid from the phase to be structured.
  • the personal care compositions of the present invention may be useful for improving or regulating a number of keratinous tissue conditions.
  • "regulating" means maintaining skin appearance and/or feel of the keratinous tissue with little to no degradation in appearance and/or feel
  • “improving” means affecting a positive change in keratinous tissue appearance and/or feel.
  • the keratinous tissue appearance and/or feel benefit may be an acute or chronic benefit.
  • Keratinous tissue conditions that may be regulated or improved include, but are not limited to thickening kerati such tissue ⁇ e.g. , building the epidermis and/or dermis and/or subcutaneous layers of the skin or lips and where applicable the keratinous layers of the nail and hair shaft including eye lashes), atrophy, softening and/or smoothing, itch, appearance of dark under-eye circles and/or puffy eyes, sallowness, sagging (e.g.
  • tanning desquamating, exfoliating, and/or increasing turnover in mammalian skin, pores size, oily/shiny appearance, hyperpigmentation such as post-inflammatory hyperpigmentation, spider vessels and/or red blotchiness on mammalian skin, fine lines and wrinkles, dryness (e.g. , roughness, scaling, flak ing), cellulite, and acne.
  • hyperpigmentation such as post-inflammatory hyperpigmentation, spider vessels and/or red blotchiness on mammalian skin, fine lines and wrinkles, dryness (e.g. , roughness, scaling, flak ing), cellulite, and acne.
  • keratinous conditions that may be regulated or improved include signs of skin aging including, but not limited to, all outward visibly and tactilely perceptible manifestations, as well as any macro- or micro-effects, due to keratinous tissue aging. These signs may result from processes which include, but are not limited to, the development of textural discontinuities such as wrinkles and coarse deep wrinkles, fine lines, skin lines, crevices, bumps, large pores, unevenness or roughness; loss of skin elasticity; discoloration (including undereye circles); blotchiness; sallowness; hyperpigmented skin regions such as age spots and freckles; keratoses; abnormal differentiation; hyperkeratinization; elastosis; collagen breakdown, and other histological changes in the stratum corneum, dermis, epidermis, vascular system (e.g. , telangiectasia or spider vessels), and underlying tissues (e.g. , fat and/or muscle), especially those proximate to the skin.
  • the personal care compositions of the present invention may be useful for improving or regulating insult-affected keratinous tissue.
  • insult-affected keratinous tissue means keratinous tissue which exhibits discomfort, irritation, an unpleasant or irregular appearance, and the like, for example after exposure to a physical and/or chemical irritant.
  • Non-limiting examples of insult-affected keratinous tissue include burn (e.g. , sunburns, windburn, chemical or thermal burns); rashes (e.g. , diaper rash, shaving rash and allergen-induced rashes); discoloration (e.g.. bleaching, staining, hyperpigmentation); nicks and cuts (e.g. , shaving insults); and dry, chapped or rough skin (e.g.
  • Non-limiting examples of insults include radiation, wind, low humidity, allergens, pollutants, chemical and natural irritants, bodily fluids, bodily waste, excessive moisture, bacteria, fungi, etc.
  • Regulating and improving keratinous tissue condition involves topically applying to the keratinous tissue a safe and effective amount of a composition of the present invention.
  • the amount of the composition that is applied, the frequency of application and the period of use will vary widely depending upon the actives and other components of a given composition and the level of regulation or improvement desired.
  • the composition is chronically applied to the keratinous tissue and, more specifically, the skin.
  • chromenic topical application routine or periodic application of the composition over a time period during the subject's lifetime. Suitable time periods include at least about one week, at least about one month, at least about three months, at least about six months, and at least about one year. Typically applications would be on the order of about once per day over such extended periods, however application rates can vary from about once per week up to about three times per day or more.
  • a wide range of quantities of the compositions of the present invention can be employed to provide a skin appearance and/or feel benefit.
  • Quantities of the present compositions which are typically applied per application, are, in mg of composition per cm ⁇ of keratinous tissue and, more specifically, the skin.
  • a suitable application quantity is from about 0.1 mg/cm ⁇ to about 20 mg/cm ⁇ or from about 0.5 mg/cm ⁇ to about 10 mg/cm ⁇ .
  • Suitable keratinous tissues to which the compositions may be employed include any part of the external portion of the face, hair, and/or nails.
  • the personal care composition may be applied to the face, lips, under-eye area, eyelids, scalp, neck, torso, arms, hands, legs, fingernails, toenails, scalp hair, eyelashes, eyebrows, and the like.
  • the personal care composition is applied to a "facial skin surface," which refers to one or more of the forehead, periorbital, cheek, perioral, chin, and nose skin surfaces.
  • Leave-on compositions may be left on the keratinous tissue for a period of at least about
  • compositions may be done using, e.g. , the palms of the hands and/or fingers, an implement, e.g., a cotton ball, swab, pad etc.
  • an implement e.g., a cotton ball, swab, pad etc.
  • the composition can be dispensed from a bottle, jar, tube, sachet, pouch, container, bottle, vial, ampoule, compact, etc. or can be integrally contained within a delivery form such as a wipe.
  • the application of the present compositions may be done using the palms of the hands and/or fingers.
  • the application may also be done with the aid of a device or implement such as a cotton ball, swab, pad, brush, eye dropper, puff, sponge, wand, wipe, foam, nonwoven substrate, mask, roll-on applicator, stick applicator, applicator pen, spray applicator, atomizer, razor, etc.
  • the active may be contained in a rupturable pouch between two substrates.
  • NTU Nephelometric Turbidity Units
  • the turbidity is measured using a l lach 21 OOP turbidity meter calibrated according to the procedure provided by the manufacture.
  • the sample vials are filled with 15ml of representative sample and capped and cleaned according to the operating instructions. If necessary, the samples are degassed to remove any bubbles either by applying a vacuum or using an ultrasonic bath (see operating manual for procedure).
  • the turbidity is measured using the automatic range selection.
  • Viscosity - Viscosities are measured on a Brookfield viscometer using a T-C bar spindle with a heliopath setting at 5 rpm at 25°C
  • MGC Minimum gelling concentration
  • Second screening prepare several vials increasing the di-amido gellant concentration in 0. 1 weight % steps in the interval determined in the first screening.
  • MGC Minimum Gelling Concentration
  • samples are prepared and treated as follows: 8mL vials (Borosilacate glass with Teflon cap, ref. B7857D, Fisher Scientific Bioblock) are filled with 2.0000+0.0005 g (KERN ALJ 1 20-4 analytical balance with ⁇ 0. 1 mg precision) of the liquid (comprising the liquid detergent composition and di-amido gellant) for which we want to determine the MGC.
  • the vial is sealed with the screw cap and left for 10 minutes in an ultrasound bath (Elma Transsonic T 710 DH, 40 kHz, 9.5L, at 25 °C and operating at 100% power) in order to disperse the solid in the liquid.
  • vapours may be formed, and upon cooling down the samples, these vapours can condense on top of the gel. When the vial is inverted, this condensed vapour will flow. This is discounted during the observation period. If no gels are obtained in the concentration interval, higher concentrations must be evaluated.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition de soins personnels comprenant un agent gélifiant di-amido, dans lequel l'agent gélifiant di-amido a une formule (I) dans laquelle R1 et R2 sont des groupes terminaux aminofonctionnels qui peuvent être identiques ou différents, et L est une fraction de liaison de masse moléculaire de 14 à 500 g/mole. La composition de soins personnels peut revêtir une diversité de formes, telles qu'une composition à application sans rinçage ou une émulsion et/ou peut comprendre un ou plusieurs actifs ou agents.
PCT/US2012/042228 2011-06-13 2012-06-13 Compositions de soins personnels comprenant un agent gélifiant di-amido et procédés d'utilisation Ceased WO2012174096A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2014515956A JP2014524901A (ja) 2011-06-13 2012-06-13 ジアミドゲル化剤を含むパーソナルケア組成物及び使用方法
EP12729303.3A EP2717966A2 (fr) 2011-06-13 2012-06-13 Compositions de soins personnels comprenant un agent gélifiant di-amido et procédés d'utilisation
CN201280028925.6A CN103930167A (zh) 2011-06-13 2012-06-13 包含二酰氨基胶凝剂的个人护理组合物和使用方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161496303P 2011-06-13 2011-06-13
US61/496,303 2011-06-13

Publications (2)

Publication Number Publication Date
WO2012174096A2 true WO2012174096A2 (fr) 2012-12-20
WO2012174096A3 WO2012174096A3 (fr) 2014-06-12

Family

ID=46331720

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/042228 Ceased WO2012174096A2 (fr) 2011-06-13 2012-06-13 Compositions de soins personnels comprenant un agent gélifiant di-amido et procédés d'utilisation

Country Status (4)

Country Link
EP (1) EP2717966A2 (fr)
JP (1) JP2014524901A (fr)
CN (1) CN103930167A (fr)
WO (1) WO2012174096A2 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015099074A1 (fr) * 2013-12-25 2015-07-02 日産化学工業株式会社 Matériau de base en forme de bâtonnet contenant un composé de peptide lipidique
US9744116B2 (en) 2013-09-18 2017-08-29 L'oreal High color intensity and easily removable mascara
US10111824B2 (en) 2014-12-29 2018-10-30 Kimberly-Clark Worldwide, Inc. Cosmetic emulsions
US10406081B2 (en) 2014-12-29 2019-09-10 Kimberly-Clark Worldwide, Inc. Multifunctional base emulsion
WO2020069251A1 (fr) * 2018-09-28 2020-04-02 L'oreal Compositions d'écran solaire minéral à efficacité améliorée

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012174091A2 (fr) * 2011-06-13 2012-12-20 The Procter & Gamble Company Compositions de soins personnels comprenant un agent gélifiant à ph accordable et procédés d'utilisation
JP6185278B2 (ja) * 2012-05-01 2017-08-23 ロート製薬株式会社 外用組成物
JP6943864B2 (ja) * 2016-01-20 2021-10-06 サン ケミカル コーポレイション 光学的に拡散する粒子

Citations (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34075A (en) 1862-01-07 Improved device for closing doors
US2396278A (en) 1933-11-15 1946-03-12 Procter & Gamble Detergent composition
US2438091A (en) 1943-09-06 1948-03-16 American Cyanamid Co Aspartic acid esters and their preparation
US2486921A (en) 1944-10-16 1949-11-01 Procter & Gamble Detergent composition
US2486922A (en) 1945-11-09 1949-11-01 Procter & Gamble Stabilized detergent composition
US2528378A (en) 1947-09-20 1950-10-31 John J Mccabe Jr Metal salts of substituted quaternary hydroxy cycloimidinic acid metal alcoholates and process for preparation of same
US2658072A (en) 1951-05-17 1953-11-03 Monsanto Chemicals Process of preparing amine sulfonates and products obtained thereof
US2694668A (en) 1952-03-10 1954-11-16 Abbott Lab Liquid multiple vitamin preparation and process of preparing the same
US2809971A (en) 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
US3152046A (en) 1956-11-09 1964-10-06 Kapral Ales Maria Selenium disulfide dispersions
US3236733A (en) 1963-09-05 1966-02-22 Vanderbilt Co R T Method of combatting dandruff with pyridinethiones metal salts detergent compositions
US3332880A (en) 1965-01-04 1967-07-25 Procter & Gamble Detergent composition
US3439088A (en) 1964-06-16 1969-04-15 Exxon Research Engineering Co Cosmetic preparations-wax rouge and foundation make-up
US3753196A (en) 1971-10-05 1973-08-14 Kulite Semiconductor Products Transducers employing integral protective coatings and supports
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US3761418A (en) 1967-09-27 1973-09-25 Procter & Gamble Detergent compositions containing particle deposition enhancing agents
US3818105A (en) 1971-08-23 1974-06-18 Exxon Research Engineering Co Composition and process for lubricating the skin
US3929678A (en) 1974-08-01 1975-12-30 Procter & Gamble Detergent composition having enhanced particulate soil removal performance
US3958581A (en) 1972-05-17 1976-05-25 L'oreal Cosmetic composition containing a cationic polymer and divalent metal salt for strengthening the hair
US3962418A (en) 1972-12-11 1976-06-08 The Procter & Gamble Company Mild thickened shampoo compositions with conditioning properties
US4032661A (en) 1972-07-20 1977-06-28 Wilkinson Sword Limited Cyclic sulphoxides and sulphones having a physiological cooling action on the human body
US4089945A (en) 1975-06-30 1978-05-16 The Procter & Gamble Company Antidandruff shampoos containing metallic cation complex to reduce in-use sulfide odor
US4136163A (en) 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
US4197865A (en) 1975-07-04 1980-04-15 L'oreal Treating hair with quaternized polymers
US4217914A (en) 1974-05-16 1980-08-19 L'oreal Quaternized polymer for use as a cosmetic agent in cosmetic compositions for the hair and skin
US4230688A (en) 1972-04-18 1980-10-28 Wilkinson Sword Limited Acyclic carboxamides having a physiological cooling effect
US4323683A (en) 1980-02-07 1982-04-06 The Procter & Gamble Company Process for making pyridinethione salts
US4345080A (en) 1980-02-07 1982-08-17 The Procter & Gamble Company Pyridinethione salts and hair care compositions
US4379753A (en) 1980-02-07 1983-04-12 The Procter & Gamble Company Hair care compositions
US4381919A (en) 1975-07-04 1983-05-03 Societe Anonyme Dite: L'oreal Hair dye composition containing quaternized polymers
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4422853A (en) 1974-05-16 1983-12-27 L'oreal Hair dyeing compositions containing quaternized polymer
US4470982A (en) 1980-12-22 1984-09-11 The Procter & Gamble Company Shampoo compositions
US4507280A (en) 1979-07-02 1985-03-26 Clairol Incorporated Hair conditioning composition and method for use
US4529586A (en) 1980-07-11 1985-07-16 Clairol Incorporated Hair conditioning composition and process
US4663158A (en) 1979-07-02 1987-05-05 Clairol Incorporated Hair conditioning composition containing cationic polymer and amphoteric surfactant and method for use
US4677120A (en) 1985-07-31 1987-06-30 Molecular Design International Topical prodrugs for treatment of acne and skin diseases
US4885107A (en) 1987-05-08 1989-12-05 The Procter & Gamble Company Shampoo compositions
US4885311A (en) 1987-06-29 1989-12-05 Molecular Design International Topical transretinoids for treatment of acne and skin diseases
US4970252A (en) 1989-02-15 1990-11-13 Shin-Etsu Chemical Company, Ltd. Oily paste composition
US4976953A (en) 1987-03-06 1990-12-11 The Procter & Gamble Company Skin conditioning/cleansing compositions containing propoxylated glycerol derivatives
US5049584A (en) 1988-12-14 1991-09-17 Molecular Design International Dermal uses of cis-retinoids for the treatment of cancer
US5104646A (en) 1989-08-07 1992-04-14 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5106609A (en) 1990-05-01 1992-04-21 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5124356A (en) 1987-06-29 1992-06-23 Molecular Design International, Inc. Dermal uses of trans-retinoids for the treatment of photoaging
US5143722A (en) 1986-12-19 1992-09-01 Revlon, Inc. Cosmetic makeup compositions comprising water-in-oil emulsions containing pigment
US5236986A (en) 1991-02-27 1993-08-17 Shin-Etsu Chemical Co., Ltd. Silicone polymers and water-dispersable, pasty silicone oil compositions comprising the same
WO1993023028A1 (fr) 1992-05-18 1993-11-25 Jean Morelle Compositions oculaires contenant de l'oleoylmethionine et de la dipalmitoylhydroxyproline
US5266592A (en) 1991-04-05 1993-11-30 Haarmann & Reimer Gmbh Compositions which have a physiological cooling effect, and active compounds suitable for these compositions
US5412004A (en) 1991-11-21 1995-05-02 Kose Corporation Silicone polymer, paste-like silicone composition, and w/o-type cosmetic composition comprising the same
US5413781A (en) 1991-01-17 1995-05-09 Dow Corning Corporation Alkylmethylsiloxanes for skin care
US5607980A (en) 1995-07-24 1997-03-04 The Procter & Gamble Company Topical compositions having improved skin feel
US5652228A (en) 1993-11-12 1997-07-29 The Procter & Gamble Company Topical desquamation compositions
US5654362A (en) 1996-03-20 1997-08-05 Dow Corning Corporation Silicone oils and solvents thickened by silicone elastomers
US5674478A (en) 1996-01-12 1997-10-07 The Procter & Gamble Company Hair conditioning compositions
US5681852A (en) 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
US5686367A (en) 1995-02-14 1997-11-11 Tdk Corporation Semiconducting ceramic composition having positive temperature coefficient of resistance and production process thereof
US5686082A (en) 1992-12-24 1997-11-11 L'oreal Cosmetic or pharmaceutical composition containing a combination of a polyphenol and a ginkgo extract
US5725845A (en) 1995-11-03 1998-03-10 Revlon Consumer Products Corporation Transfer resistant cosmetic stick compositions with semi-matte finish
US5750122A (en) 1996-01-16 1998-05-12 The Procter & Gamble Company Compositions for treating hair or skin
US5760116A (en) 1996-09-05 1998-06-02 General Electric Company Elastomer gels containing volatile, low molecular weight silicones
US5811487A (en) 1996-12-16 1998-09-22 Dow Corning Corporation Thickening silicones with elastomeric silicone polyethers
US5837793A (en) 1996-03-22 1998-11-17 Dow Corning Toray Silicone Co., Ltd. Silicone rubber powder and method for the preparation thereof
US5922758A (en) 1994-09-21 1999-07-13 The Procter & Gamble Company Methods and compositions employing 2,4-dienoic acid esters of tocopherols to prevent or reduce skin damage
US5939082A (en) 1995-11-06 1999-08-17 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
US5993789A (en) 1999-03-25 1999-11-30 The C.P. Hall Company Photostable sunscreen compositions containing dibenzoylmethane derivative, E.G., parsol® 1789, and diesters or polyesters of naphthalene dicarboxylic acid photostabilizers and enhancers of the sun protection factor (SPF)
US5997887A (en) 1997-11-10 1999-12-07 The Procter & Gamble Company Skin care compositions and method of improving skin appearance
US6113931A (en) 1999-03-25 2000-09-05 The C.P. Hall Company Clear formulations containing diesters or polyesters of naphthalene dicarboxylic acid
US6126925A (en) 1999-03-25 2000-10-03 The C. P. Hall Company Photostable sunscreen compositions containing dibenzoylmethane derivative, e.g., PARSOL® 1789, and diesters of naphthalene dicarboxylic acid photostabilizers and enhancers of the sun protection factor (SPF)
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US20020041889A1 (en) 1997-03-31 2002-04-11 Yoshiko Masuda Enhancing agent for degradation of desmosomes or stratum corneum desquamation
US20020131948A1 (en) 1999-03-22 2002-09-19 L'oreal Tightening agent comprising at least one grafted silicone polymer
WO2002076423A2 (fr) 2001-03-22 2002-10-03 The Procter & Gamble Company Compositions de soin cutane contenant un amino-sucre
US6524598B2 (en) 2000-07-10 2003-02-25 The Procter & Gamble Company Cosmetic compositions
US20030108492A1 (en) 2001-07-16 2003-06-12 Em Industries Photo stable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
US20030157035A1 (en) 2001-12-20 2003-08-21 Em Industries Photo stable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
US6696049B2 (en) 2000-07-10 2004-02-24 The Procter & Gamble Company Cosmetic compositions
US20040057912A1 (en) 2002-09-17 2004-03-25 Bonda Craig A. Novel photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition
WO2004024798A1 (fr) 2002-09-12 2004-03-25 Shin-Etsu Chemical Co., Ltd. Nouveau polymere organopolysiloxane, composition pateuse, et preparation cosmetique contenant cette composition
US20040057916A1 (en) 2002-09-17 2004-03-25 The C.P. Hall Company Novel photostabilizers, UV absorbers, and methods of photostablizing a sunscreen composition
US20040057920A1 (en) 2002-09-20 2004-03-25 The Procter & Gamble Company Striped liquid personal cleansing compositions containing a cleansing phase and a seperate benefit phase
US20040062726A1 (en) 2002-09-17 2004-04-01 Bonda Craig A. Novel photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition
US20040170586A1 (en) 2002-06-12 2004-09-02 L'oreal Cosmetic composition containing a polyorganosiloxane polymer
US20040219119A1 (en) 2003-05-01 2004-11-04 The Procter & Gamble Company Visually distinctive multiple liquid phase compositions
US6872401B2 (en) 2002-03-28 2005-03-29 L'oreal Cosmetic/dermatological compositions comprising a tetrahydrocurcuminoid and an amide oil
US20050220727A1 (en) 2002-05-02 2005-10-06 Lupia Joseph A Stabilized body care products, household products, textiles and fabrics
US20060134045A1 (en) 2004-12-17 2006-06-22 Hongjie Cao Personal care compositions comprising plant fiber
US20060147396A1 (en) 2005-01-03 2006-07-06 L'oreal Composition containing ascorbic acid
US20070020220A1 (en) 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
US20070039103A1 (en) 2005-08-17 2007-02-22 The Procter & Gamble Company Fiber and hair fiber conditioning treatment composition
US20070140993A1 (en) 2004-02-19 2007-06-21 Reckitt & Colman (Overseas) Limited Skincare compositions
US7285570B2 (en) 2003-04-17 2007-10-23 The Procter & Gamble Company Compositions and methods for regulating mammalian keratinous tissue
US20070297996A1 (en) 2006-06-22 2007-12-27 The Procter & Gamble Company Multi-phase composition comprising a sunscreen
US20080019930A1 (en) 2006-06-23 2008-01-24 L'oreal Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds
US7332529B2 (en) 2004-10-26 2008-02-19 Carr Andrew J Thermoreversible organogelators, compositions and methods of making thereof
US7357919B2 (en) 2004-10-19 2008-04-15 L'oreal Photostable photoprotective compositions comprising dibenzoylmethane and arylalkyl benzoate compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s)
US20080145324A1 (en) 2005-05-31 2008-06-19 L'oreal UV-photoprotective compositions comprising diebenzoylmethane screening agents and silicon-containing s-triazine compounds substituted with two aminobenzoate or aminobenzamide groups
US20100112100A1 (en) 2007-03-12 2010-05-06 L'oreal Compositions comprising a c-glycoside compound
US7713519B2 (en) 2007-08-09 2010-05-11 Hallstar Innovations Corp. Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions
US20100183529A1 (en) 2008-12-08 2010-07-22 L'oreal Cosmetic compositions comprising photostabilized dibenzoylmethane compounds and 2-pyrrolidinone-4- carboxy esters
US20100189669A1 (en) 2009-01-29 2010-07-29 Tomohiro Hakozaki Regulation of Mammalian Keratinous Tissue Using Skin and/or Hair Care Actives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4149994B2 (ja) * 2002-06-12 2008-09-17 ロレアル シリコーンポリマーおよびオルガノゲル化剤によって構造化された固形のケア用および／またはメークアップ用組成物
US8003086B2 (en) * 2006-05-09 2011-08-23 L'oreal S.A. Bis-urea compounds and compositions and method of cosmetic treatment
FR2900819B1 (fr) * 2006-05-09 2010-10-15 Oreal Compose de type bis-uree, composition le comprenant, utilisation et procede de traitement cosmetique
FR2910807A1 (fr) * 2006-12-29 2008-07-04 Oreal Composition cosmetique comprenant un derive de bis uree.
CA2791251C (fr) * 2010-03-12 2014-08-12 The Procter & Gamble Company Compositions detergentes fluides comprenant un gelifiant di-amido et leurs procedes de fabrication
WO2012174091A2 (fr) * 2011-06-13 2012-12-20 The Procter & Gamble Company Compositions de soins personnels comprenant un agent gélifiant à ph accordable et procédés d'utilisation

Patent Citations (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34075A (en) 1862-01-07 Improved device for closing doors
US2396278A (en) 1933-11-15 1946-03-12 Procter & Gamble Detergent composition
US2438091A (en) 1943-09-06 1948-03-16 American Cyanamid Co Aspartic acid esters and their preparation
US2486921A (en) 1944-10-16 1949-11-01 Procter & Gamble Detergent composition
US2486922A (en) 1945-11-09 1949-11-01 Procter & Gamble Stabilized detergent composition
US2528378A (en) 1947-09-20 1950-10-31 John J Mccabe Jr Metal salts of substituted quaternary hydroxy cycloimidinic acid metal alcoholates and process for preparation of same
US2658072A (en) 1951-05-17 1953-11-03 Monsanto Chemicals Process of preparing amine sulfonates and products obtained thereof
US2694668A (en) 1952-03-10 1954-11-16 Abbott Lab Liquid multiple vitamin preparation and process of preparing the same
US2809971A (en) 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
US3152046A (en) 1956-11-09 1964-10-06 Kapral Ales Maria Selenium disulfide dispersions
US3236733A (en) 1963-09-05 1966-02-22 Vanderbilt Co R T Method of combatting dandruff with pyridinethiones metal salts detergent compositions
US3439088A (en) 1964-06-16 1969-04-15 Exxon Research Engineering Co Cosmetic preparations-wax rouge and foundation make-up
US3332880A (en) 1965-01-04 1967-07-25 Procter & Gamble Detergent composition
US3761418A (en) 1967-09-27 1973-09-25 Procter & Gamble Detergent compositions containing particle deposition enhancing agents
US4136163A (en) 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US3818105A (en) 1971-08-23 1974-06-18 Exxon Research Engineering Co Composition and process for lubricating the skin
US3753196A (en) 1971-10-05 1973-08-14 Kulite Semiconductor Products Transducers employing integral protective coatings and supports
US4230688A (en) 1972-04-18 1980-10-28 Wilkinson Sword Limited Acyclic carboxamides having a physiological cooling effect
US3958581A (en) 1972-05-17 1976-05-25 L'oreal Cosmetic composition containing a cationic polymer and divalent metal salt for strengthening the hair
US4032661A (en) 1972-07-20 1977-06-28 Wilkinson Sword Limited Cyclic sulphoxides and sulphones having a physiological cooling action on the human body
US3962418A (en) 1972-12-11 1976-06-08 The Procter & Gamble Company Mild thickened shampoo compositions with conditioning properties
US4422853A (en) 1974-05-16 1983-12-27 L'oreal Hair dyeing compositions containing quaternized polymer
US4217914A (en) 1974-05-16 1980-08-19 L'oreal Quaternized polymer for use as a cosmetic agent in cosmetic compositions for the hair and skin
US3929678A (en) 1974-08-01 1975-12-30 Procter & Gamble Detergent composition having enhanced particulate soil removal performance
US4089945A (en) 1975-06-30 1978-05-16 The Procter & Gamble Company Antidandruff shampoos containing metallic cation complex to reduce in-use sulfide odor
US4197865A (en) 1975-07-04 1980-04-15 L'oreal Treating hair with quaternized polymers
US4381919A (en) 1975-07-04 1983-05-03 Societe Anonyme Dite: L'oreal Hair dye composition containing quaternized polymers
US4663158A (en) 1979-07-02 1987-05-05 Clairol Incorporated Hair conditioning composition containing cationic polymer and amphoteric surfactant and method for use
US4507280A (en) 1979-07-02 1985-03-26 Clairol Incorporated Hair conditioning composition and method for use
US4345080A (en) 1980-02-07 1982-08-17 The Procter & Gamble Company Pyridinethione salts and hair care compositions
US4323683A (en) 1980-02-07 1982-04-06 The Procter & Gamble Company Process for making pyridinethione salts
US4379753A (en) 1980-02-07 1983-04-12 The Procter & Gamble Company Hair care compositions
US4529586A (en) 1980-07-11 1985-07-16 Clairol Incorporated Hair conditioning composition and process
US4470982A (en) 1980-12-22 1984-09-11 The Procter & Gamble Company Shampoo compositions
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4677120A (en) 1985-07-31 1987-06-30 Molecular Design International Topical prodrugs for treatment of acne and skin diseases
US5143722B1 (en) 1986-12-19 1999-08-24 Revlon Consumer Prod Corp Cosmetic makeup compositions comprising water-in-oil emulsions containing pigment
US5143722A (en) 1986-12-19 1992-09-01 Revlon, Inc. Cosmetic makeup compositions comprising water-in-oil emulsions containing pigment
US4976953A (en) 1987-03-06 1990-12-11 The Procter & Gamble Company Skin conditioning/cleansing compositions containing propoxylated glycerol derivatives
US4885107A (en) 1987-05-08 1989-12-05 The Procter & Gamble Company Shampoo compositions
US4885311A (en) 1987-06-29 1989-12-05 Molecular Design International Topical transretinoids for treatment of acne and skin diseases
US5124356A (en) 1987-06-29 1992-06-23 Molecular Design International, Inc. Dermal uses of trans-retinoids for the treatment of photoaging
US5049584A (en) 1988-12-14 1991-09-17 Molecular Design International Dermal uses of cis-retinoids for the treatment of cancer
US4970252A (en) 1989-02-15 1990-11-13 Shin-Etsu Chemical Company, Ltd. Oily paste composition
US5104646A (en) 1989-08-07 1992-04-14 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5106609A (en) 1990-05-01 1992-04-21 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
US5413781A (en) 1991-01-17 1995-05-09 Dow Corning Corporation Alkylmethylsiloxanes for skin care
US5236986A (en) 1991-02-27 1993-08-17 Shin-Etsu Chemical Co., Ltd. Silicone polymers and water-dispersable, pasty silicone oil compositions comprising the same
US5266592A (en) 1991-04-05 1993-11-30 Haarmann & Reimer Gmbh Compositions which have a physiological cooling effect, and active compounds suitable for these compositions
US5412004A (en) 1991-11-21 1995-05-02 Kose Corporation Silicone polymer, paste-like silicone composition, and w/o-type cosmetic composition comprising the same
WO1993023028A1 (fr) 1992-05-18 1993-11-25 Jean Morelle Compositions oculaires contenant de l'oleoylmethionine et de la dipalmitoylhydroxyproline
US5686082A (en) 1992-12-24 1997-11-11 L'oreal Cosmetic or pharmaceutical composition containing a combination of a polyphenol and a ginkgo extract
US5652228A (en) 1993-11-12 1997-07-29 The Procter & Gamble Company Topical desquamation compositions
US5681852A (en) 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
US5922758A (en) 1994-09-21 1999-07-13 The Procter & Gamble Company Methods and compositions employing 2,4-dienoic acid esters of tocopherols to prevent or reduce skin damage
US5686367A (en) 1995-02-14 1997-11-11 Tdk Corporation Semiconducting ceramic composition having positive temperature coefficient of resistance and production process thereof
US5607980A (en) 1995-07-24 1997-03-04 The Procter & Gamble Company Topical compositions having improved skin feel
US5725845A (en) 1995-11-03 1998-03-10 Revlon Consumer Products Corporation Transfer resistant cosmetic stick compositions with semi-matte finish
US5939082A (en) 1995-11-06 1999-08-17 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
US5674478A (en) 1996-01-12 1997-10-07 The Procter & Gamble Company Hair conditioning compositions
US5750122A (en) 1996-01-16 1998-05-12 The Procter & Gamble Company Compositions for treating hair or skin
US5654362A (en) 1996-03-20 1997-08-05 Dow Corning Corporation Silicone oils and solvents thickened by silicone elastomers
US5837793A (en) 1996-03-22 1998-11-17 Dow Corning Toray Silicone Co., Ltd. Silicone rubber powder and method for the preparation thereof
US5760116A (en) 1996-09-05 1998-06-02 General Electric Company Elastomer gels containing volatile, low molecular weight silicones
US5811487A (en) 1996-12-16 1998-09-22 Dow Corning Corporation Thickening silicones with elastomeric silicone polyethers
US20020041889A1 (en) 1997-03-31 2002-04-11 Yoshiko Masuda Enhancing agent for degradation of desmosomes or stratum corneum desquamation
US5997887A (en) 1997-11-10 1999-12-07 The Procter & Gamble Company Skin care compositions and method of improving skin appearance
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US20020131948A1 (en) 1999-03-22 2002-09-19 L'oreal Tightening agent comprising at least one grafted silicone polymer
US6126925A (en) 1999-03-25 2000-10-03 The C. P. Hall Company Photostable sunscreen compositions containing dibenzoylmethane derivative, e.g., PARSOL® 1789, and diesters of naphthalene dicarboxylic acid photostabilizers and enhancers of the sun protection factor (SPF)
US5993789A (en) 1999-03-25 1999-11-30 The C.P. Hall Company Photostable sunscreen compositions containing dibenzoylmethane derivative, E.G., parsol® 1789, and diesters or polyesters of naphthalene dicarboxylic acid photostabilizers and enhancers of the sun protection factor (SPF)
US6284916B1 (en) 1999-03-25 2001-09-04 The C.P. Hall Company Diesters of naphthalene dicarboxylic acid
US6113931A (en) 1999-03-25 2000-09-05 The C.P. Hall Company Clear formulations containing diesters or polyesters of naphthalene dicarboxylic acid
US6524598B2 (en) 2000-07-10 2003-02-25 The Procter & Gamble Company Cosmetic compositions
US6696049B2 (en) 2000-07-10 2004-02-24 The Procter & Gamble Company Cosmetic compositions
WO2002076423A2 (fr) 2001-03-22 2002-10-03 The Procter & Gamble Company Compositions de soin cutane contenant un amino-sucre
US20030108492A1 (en) 2001-07-16 2003-06-12 Em Industries Photo stable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
US20030157035A1 (en) 2001-12-20 2003-08-21 Em Industries Photo stable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
US6872401B2 (en) 2002-03-28 2005-03-29 L'oreal Cosmetic/dermatological compositions comprising a tetrahydrocurcuminoid and an amide oil
US20050220727A1 (en) 2002-05-02 2005-10-06 Lupia Joseph A Stabilized body care products, household products, textiles and fabrics
US20040170586A1 (en) 2002-06-12 2004-09-02 L'oreal Cosmetic composition containing a polyorganosiloxane polymer
WO2004024798A1 (fr) 2002-09-12 2004-03-25 Shin-Etsu Chemical Co., Ltd. Nouveau polymere organopolysiloxane, composition pateuse, et preparation cosmetique contenant cette composition
US20040057914A1 (en) 2002-09-17 2004-03-25 Bonda Craig A. Novel photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition
US20040062726A1 (en) 2002-09-17 2004-04-01 Bonda Craig A. Novel photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition
US20040057916A1 (en) 2002-09-17 2004-03-25 The C.P. Hall Company Novel photostabilizers, UV absorbers, and methods of photostablizing a sunscreen composition
US20040057912A1 (en) 2002-09-17 2004-03-25 Bonda Craig A. Novel photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition
US20040057920A1 (en) 2002-09-20 2004-03-25 The Procter & Gamble Company Striped liquid personal cleansing compositions containing a cleansing phase and a seperate benefit phase
US7285570B2 (en) 2003-04-17 2007-10-23 The Procter & Gamble Company Compositions and methods for regulating mammalian keratinous tissue
US20040219119A1 (en) 2003-05-01 2004-11-04 The Procter & Gamble Company Visually distinctive multiple liquid phase compositions
US20070140993A1 (en) 2004-02-19 2007-06-21 Reckitt & Colman (Overseas) Limited Skincare compositions
US7357919B2 (en) 2004-10-19 2008-04-15 L'oreal Photostable photoprotective compositions comprising dibenzoylmethane and arylalkyl benzoate compounds and a compound that accepts the excited triplet level energy of said dibenzoylmethane(s)
US7332529B2 (en) 2004-10-26 2008-02-19 Carr Andrew J Thermoreversible organogelators, compositions and methods of making thereof
US20060134045A1 (en) 2004-12-17 2006-06-22 Hongjie Cao Personal care compositions comprising plant fiber
US20060147396A1 (en) 2005-01-03 2006-07-06 L'oreal Composition containing ascorbic acid
US20070020220A1 (en) 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
US20080145324A1 (en) 2005-05-31 2008-06-19 L'oreal UV-photoprotective compositions comprising diebenzoylmethane screening agents and silicon-containing s-triazine compounds substituted with two aminobenzoate or aminobenzamide groups
US20070039103A1 (en) 2005-08-17 2007-02-22 The Procter & Gamble Company Fiber and hair fiber conditioning treatment composition
US20070297996A1 (en) 2006-06-22 2007-12-27 The Procter & Gamble Company Multi-phase composition comprising a sunscreen
US20080019930A1 (en) 2006-06-23 2008-01-24 L'oreal Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds
US20100112100A1 (en) 2007-03-12 2010-05-06 L'oreal Compositions comprising a c-glycoside compound
US7713519B2 (en) 2007-08-09 2010-05-11 Hallstar Innovations Corp. Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions
US20100183529A1 (en) 2008-12-08 2010-07-22 L'oreal Cosmetic compositions comprising photostabilized dibenzoylmethane compounds and 2-pyrrolidinone-4- carboxy esters
US20100189669A1 (en) 2009-01-29 2010-07-29 Tomohiro Hakozaki Regulation of Mammalian Keratinous Tissue Using Skin and/or Hair Care Actives

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
"International Cosmetic Ingredient Dictionary and Handbook", 2006, article "Personal Care Product Council's"
"International Cosmetic Ingredient Dictionary and Handbook", 2010, article "The Personal Care Product Council's"
"McCutcheon's, Emulsifiers and Detergents", 2010, M. C. PUBLISHING CO.
MCCUTCHEON'S: "Emulsifiers and Detergents", 2010, M. C. PUBLISHING CO.
P.J. KOCIENSKI: "Protecting Groups", GEORG THIEME VERLAG
R.G. WEISS; P. TERECH: "Molecular Gels: Materials with self-assembled fibrillar structures", 2006, SPRINGER, pages: 243
STRYER: "Biochemistry", 1981, W.H. FREEMAN AND COMPANY
T.W. GREENE; P.G.M. WUTS: "Protective Groups in Organic Chemistry", JOHN WILEY& SONS, INC
UNKNOWN: "Personal Care Product Council's International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition,", 2010

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9744116B2 (en) 2013-09-18 2017-08-29 L'oreal High color intensity and easily removable mascara
WO2015099074A1 (fr) * 2013-12-25 2015-07-02 日産化学工業株式会社 Matériau de base en forme de bâtonnet contenant un composé de peptide lipidique
CN105848631A (zh) * 2013-12-25 2016-08-10 日产化学工业株式会社 含有脂质肽型化合物的棒状基材
JPWO2015099074A1 (ja) * 2013-12-25 2017-03-23 日産化学工業株式会社 脂質ペプチド型化合物を含有するスティック状基材
US10092496B2 (en) 2013-12-25 2018-10-09 Nissan Chemical Industries, Ltd. Stick-shaped base material containing lipid peptide compound
CN112891245A (zh) * 2013-12-25 2021-06-04 日产化学工业株式会社 含有脂质肽型化合物的棒状基材
US10111824B2 (en) 2014-12-29 2018-10-30 Kimberly-Clark Worldwide, Inc. Cosmetic emulsions
US10406081B2 (en) 2014-12-29 2019-09-10 Kimberly-Clark Worldwide, Inc. Multifunctional base emulsion
WO2020069251A1 (fr) * 2018-09-28 2020-04-02 L'oreal Compositions d'écran solaire minéral à efficacité améliorée
US10813870B2 (en) 2018-09-28 2020-10-27 L'oreal Mineral sunscreen compositions with improved efficacy

Also Published As

Publication number Publication date
EP2717966A2 (fr) 2014-04-16
JP2014524901A (ja) 2014-09-25
CN103930167A (zh) 2014-07-16
WO2012174096A3 (fr) 2014-06-12

Similar Documents

Publication Publication Date Title
US9271912B2 (en) Personal care compositions comprising a pH tuneable gellant and methods of using
US11160734B2 (en) Personal care compositions comprising shaped abrasive particles
US11986548B2 (en) Hydrophobic topical compositions and methods for producing same
EP2717966A2 (fr) Compositions de soins personnels comprenant un agent gélifiant di-amido et procédés d'utilisation
JP6092900B2 (ja) Ｕｖ複合体を含む日焼け止め剤組成物
WO2012174091A2 (fr) Compositions de soins personnels comprenant un agent gélifiant à ph accordable et procédés d'utilisation
US20130336902A1 (en) Personal Care Compositions Comprising a Di-Amido Gellant and Methods of Using
ES2401935T3 (es) Sistema de emulsionante
JP2022044035A (ja) 乳化組成物
KR20050053023A (ko) 지질 함량이 높은 분무 가능한 에멀젼
AU2004238310A1 (en) Personal care compositions containing a silicone elastomer and a dispersed oil phase
BR112016013110A2 (pt) partículas compósitas, composição e métodos cosméticos para o cuidado e/ou maquiagem de uma substância queratinosa, para limitar o bronzeado da pele e para o tratamento de envelhecimento de uma substância queratinosa
WO2014070834A1 (fr) Compositions de soins personnels comprenant des peptides à auto-assemblage
TW202412830A (zh) 個人護理組合物
JP6783511B2 (ja) 皮膚外用剤
JP2006151901A (ja) 噴霧可能な水中油型乳剤
AU2023243125A1 (en) Personal care compositions for sensitive skin and methods of use
HK40122903A (zh) 用於敏感皮肤的个人护理组合物和其使用方法
JP2016522193A (ja) 標準エマルジョン系生成物の差別化

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12729303

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2012729303

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2014515956

Country of ref document: JP

Kind code of ref document: A